Cross-Section Analysis of Vitamin D Status on Muscle Strength and Power in Ncaa Athletes by Hildebrand, Rachel
A CROSS-SECTION ANALYSIS OF VITAMIN D 
STATUS ON MUSCLE STRENGTH 
AND POWER IN NCAA 
ATHLETES 
 
   By 
      RACHEL ANN HILDEBRAND 
   Bachelor of Science in Athletic Training  
The University of Tulsa 
   Tulsa, Oklahoma 
   2006 
 
   Master of Education in Sport Administration  
   Xavier University 
   Cincinnati, Ohio 
   2009 
 
 
   Submitted to the Faculty of the 
   Graduate College of the 
   Oklahoma State University 
   in partial fulfillment of 
   the requirements for 
   the Degree of 
   DOCTOR OF PHILOSOPHY  
July, 2013  
iii 
 
   A CROSS-SECTION ANALYSIS OF VITAMIN D STATUS ON MUSCLE 
STRENGTH AND POWER IN NCAA 
ATHLETES 
 
 
   Dissertation Approved: 
 
  Steve Edwards, PhD 
  Dissertation Adviser 
  Brenda Smith, PhD 
 
   Bridget Miller, PhD 
 
  Aric Warren, EdD 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
Acknowledgements reflect the views of the author and are not endorsed by committee 
members or Oklahoma State University. 
 
 
ACKNOWLEDGEMENTS 
 
First I would like to thank Mid-America Athletic Trainers Association and the 
Cooper Institute for all the support and monetary donations to be able to complete this 
project. It would not have been possible without their help. I would also like to thank my 
committee for all their guidance through the course of the project.  
Thank you to Dr. Brenda Smith for all the hours of helping me navigate through 
the readings, the data and material and challenging me every day to be better and to not 
give up. Thank you for being there though all the twist and turns this project presented 
and encouraging me to stick with it. 
I would like to thank my friends and fellow graduate assistants who were there 
with me as we compared notes, told each other what to expect and supported each other 
when times were down. You all were invaluable to me and I will cherish the friendships 
we have made together.  
Last, I would like to thank my family. Without your love and support this would 
not have been possible. From all the hours of praying to hours of volunteered time I 
cannot thank you enough. You all have loved me through the elations of great news to the 
frustrations of disappointing news and have been there support me and encourage me to 
keep going and to preserver. You believed in me before I believed in myself. I know I 
would not be here today without you. I love you all.  
 
v 
 
Name: RACHEL ANN HILDEBAND  
 
Date of Degree: MAY, 2013 
  
Title of Study: A CROSS-SECTION ANALYSIS OF VITAMIN D STATUS ON 
MUSCLE STRENGTH AND POWER IN NCAA ATHLETES 
Major Field: HEALTH AND HUMAN PERFORMANCE 
 
Abstract:  
 
Purpose: The purpose of this study was to assess the prevalence of vitamin D inadequacy 
in collegiate athletes and to determine the influence of serum vitamin D (25-OH D) on 
muscle strength and power in this population.  
Methods: Demographic and anthropometric data were collected on collegiate athletes 
(n=103) from three separate NCAA athletic programs.  Dietary vitamin D and calcium 
intake, and sun exposure were assessed using validated questionnaires. Serum 25-OH D 
was evaluated and a series of physical performance measures that are established 
indicators of muscular strength and power were completed. The performance measures 
included the Vertical Jump Test, Shuttle Run Test, Triple Hop for Distance Test and the 1 
Repetition Maximum (1 RM) Squat Test. Categorical data were evaluated using Chi 
Square and Pearson Correlations were performed to examine the relationship between 
serum vitamin D and performance measures.  Comparisons between groups were 
accomplished using ANCOVA with lean body mass as a covariate.  
Results: Using serum 25-OH D concentrations of 30 ng/mL and 20 ng/mL as the cutoff 
points for insufficient and deficient status, 68% of the study participants were considered 
vitamin D adequate, while 22.7% were insufficient and 8.9% were deficient. Analyses 
using ANCOVA revealed a lower (p < 0.05) 1 RM Squat Test when adjusting for lean 
body mass with vitamin D deficiency. However, no other performance measures were 
significantly different.    
Discussion: These findings suggest that the majority of this population of collegiate 
athletes were vitamin D sufficient. Athletes with adequate vitamin D status may have an 
ergogenic advantage in terms of the 1 RM Squat compared to those who are vitamin D 
inadequate. Further research is needed to determine the potential implications of these 
findings on athletic performance and studies are warranted to determine if vitamin D 
supplementation can improve performance outcomes.  
Key Words: VITAMIN D, 25-OH D, MUSCLE STRENGTH, MUSCLE POWER, 
ATHLETES 
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CHAPTER I 
 
 
INTRODUCTION 
 Current estimates indicate that approximately 1 billion people worldwide suffer from 
suboptimal serum vitamin D levels (i.e., vitamin D insufficiency or deficiency)
1
. Inadequate 
vitamin D status, defined as serum 25-hydroxyvitamin D (25-OH D) < 30 ng/mL, is known to 
alter calcium homeostasis and have detrimental effects on bone health. The increasing incidence 
of vitamin D insufficiency and deficiency has become a growing concern among many allied 
healthcare professionals in the U.S., especially as the scientific literature has indicated that 
vitamin D is also associated with a variety of chronic diseases (e.g., diabetes mellitus, certain 
cancers, and depression) and impaired physical function
2-4
.  
In addition to influencing chronic disease and physical capacity, vitamin D status can, in 
itself, be affected by factors such as the age, ethnicity, exposure to the sun, dietary intake and 
body composition of an individual
2
. It is clear that as an individual ages, the ability to synthesize 
cutaneous vitamin D decreases, leading to a greater prevalence of vitamin D inadequacy among 
older adults
5
. Ethnicity also contributes to vitamin D deficiency
6
. For example, in a sample of 
Caucasian 9-11 year olds, 48% were vitamin D inadequate, while 57% of healthy Caucasian older 
adults were reported to be inadequate
3,5
. Among a sample of healthy older African American 
adults, the prevalence of vitamin D inadequacy was as high as 84%
3
.
2 
 
The average adult synthesizes most of their daily vitamin D requirement subcutaneously from 
exposure to ultraviolet rays
4
. However, exposure to sun is limited for some populations due to 
seasonal changes in the sun’s zenith angle or latitude of residence, leaving the diet to serve as an 
alternative source of vitamin D
6
. According to the Institute of Medicine’s 2010 recommendations, the 
daily recommended intake of vitamin D for people ages 9-70 years is 600 International Units 
(IU)/day
7
. Vitamin D, naturally found in foods such as oily fish and shiitake mushrooms, is also 
fortified into foods such as dairy products and certain grains in the United States
8,9
.  Although most 
adults meet their daily macronutrient needs
10
, many individuals have inadequate intake of several 
micronutrients due to unhealthy food choices
10,11
. Among college-aged students in particular, study 
habits, social interaction, cost, convenience, and belief all influence dietary intake
10-13
. The limited 
dietary sources of vitamin D (i.e. natural and fortified) are often expensive and may be cost 
prohibitive for many students. Additionally, vitamin D can be sequestered within the adipose tissue
14
 
and so body composition and distribution of body fat can play a role in the vitamin D status of an 
individual
14
. Therefore, individuals with excessive subcutaneous adiposity are at greater risk of 
having inadequate serum levels of vitamin D.  These factors may contribute to the increase in vitamin 
D insufficiency observed in the young adult population.  
In addition to vitamin D’s role in bone health and disease prevention, accumulating scientific 
evidence demonstrates a strong relationship between serum 25-OH D and muscle strength and muscle 
power
1,8,15-18
. Populations studied vary based on factors that influence vitamin D status such as age, 
ethnicity, latitude of residence and occupation
17,19-26
. Studies have shown older adult, young adult and 
adolescent populations experienced significant improvements in lower extremity muscle function 
when serum vitamin D status was sufficient (i.e., > 30 ng/mL)
1,13,19-22
. In a cross section of older 
adults, the positive correlation between vitamin D status and muscle strength was demonstrated by a 
decrease in the incidence of falls as well as an increase in grip strength in those whose vitamin D 
status improved from inadequate to adequate
25
. Importantly, the greatest strength gains were seen in 
individuals who progressed from deficient to sufficient, but muscle strength and power gains 
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continued to be positively correlated even for those individuals who were considered vitamin D 
adequate
25,26
. In a cross-sectional study of children and adolescents, muscular strength and muscular 
power, as indicated by vertical jump or squat jump score, were positively correlated with vitamin D 
status
17
. Also, young adults with suboptimal serum concentrations of vitamin D (< 30ng/mL), who 
were recovering from an anterior cruciate ligament (ACL) reconstruction, were slower to obtain pre-
surgical strength than young adults with the same surgical procedure who were vitamin D sufficient
27
.  
A major role of vitamin D in maintaining muscle function during physical activity is 
regulating the availability of the micronutrients, calcium and phosphorus 
26,28
. Vitamin D aids in the 
absorption and transport of calcium and phosphorus to the muscles
28
. The mechanisms by which 
vitamin D improves muscle function have been associated with: 1) effective influx and uptake of 
calcium, 2) increased phosphate metabolism, and 3) enhanced muscle cell proliferation and 
differentiation
28-32
. The effect of 1α,25-OH2 D, the biologically active form of vitamin D, on calcium 
is attributed primarily to the interaction with the plasma membrane vitamin D receptor (mVDR)
28,32
. 
This interaction is non-genomic, (i.e., outside the nucleus), and involves the rapid mobilization of 
calcium from the sarcoplasmic reticulum, stored calcium within the cytoplasm and extracellular 
calcium that is regulated by the voltage dependent calcium channels
16,28,32
. Vitamin D mediated 
phosphate metabolism is also non-genomic with vitamin D regulating the absorption and availability 
of free phosphate and adenosine tri-phosphate (ATP) utilized in muscle contractions
28
. In contrast, 
vitamin D also has genomic effects on muscle cell proliferation and differentiation that are initiated 
by the interaction of vitamin D and the VDR which in turn elicits a cascade of events that lead to 
myogenesis
28
.  
Despite continued efforts to understand the mechanism by which vitamin D status affects 
muscle function, and the supporting evidence that vitamin D is positively correlated with muscular 
strength and muscular power in certain populations, there is limited data examining the relationship 
between muscle function and vitamin D status for the purposes of improving muscular strength and 
muscular power in the collegiate athlete
28,33,34
. Previously, athletes, ranging from junior high to elite 
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competitors, have been shown to have a high prevalence of vitamin D insufficiency
33-39
. Lovell
38
 
reported that 100% of the female elite gymnasts they studied had serum concentrations of vitamin D 
in the suboptimal range, while Lehtonon-Veromaa and colleagues
36
 reported that 68% of adolescent 
runners and gymnasts were vitamin D insufficient. In a recent meta-analysis examining the 
prevalence of vitamin D insufficiency, the authors found consistency in the research that few 
collegiate athletes met the dietary intake of 600 IU per day
34
. Willis, et al
37
, estimated that elite 
athletes only consume ~330 IU of vitamin D per day, rendering them vitamin D insufficient if 
sunlight exposure is limited. However, the question remains as to the extent to which an athlete’s 
serum vitamin D is related to muscular strength and muscular power, which are measures of athletic 
performance.  
Formal Statement of the Problem 
Studies have shown a positive correlation between serum 25-OH D and muscular strength 
and muscular power in non-athletic populations. Moreover, with improved 25-OH D status, muscle 
strength and power were increased in these populations.  However, few studies have examined the 
correlation of vitamin D status to muscle strength and muscle power in collegiate athletes.  
Purpose of the Study 
The purpose of this study is to assess the prevalence of vitamin D inadequacy in collegiate 
athletes and to determine the influence of vitamin D status on measures of muscular strength and 
muscular power in highly trained NCAA collegiate athletes.  
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Significance of the Study  
The aim of this research is to determine the relationship of vitamin D status on muscle 
strength and muscle power by evaluating performance measures related to lower body strength and 
power. Athletes often search for ergogenic aids that can provide them with a competitive edge
40
. By 
better understanding the relationship between vitamin D status and muscle strength and muscle power 
in the collegiate athletic population, investigators will be able to determine if vitamin D 
supplementation studies are warranted.  
Null Hypotheses  
The primary null hypotheses tested are: 
1) There will be no participants who are vitamin D deficient/insufficient in cross-section of 
collegiate athletes.  
2) Collegiate athletes with sufficient vitamin D status will not have higher Vertical Jump 
Test scores than those who are insufficient or deficient.  
3) Collegiate athletes with sufficient vitamin D status will not have lower Shuttle Run Test 
times than those who are insufficient or deficient. 
4) Collegiate athletes with sufficient vitamin D status will not have longer Triple Hop for 
Distance Test scores than those who are insufficient or deficient. 
5) Collegiate athletes with sufficient vitamin D status will not have higher 1 Repetition 
Maximum (1 RM) Squat scores than those who are insufficient or deficient. 
6) Collegiate athletes with sufficient vitamin D status will not have greater muscle power 
output scores based on the Vertical Jump Test than those who are insufficient or 
deficient. 
7) Collegiate athletes with sufficient vitamin D status will not have greater muscle force 
output scores based on the Vertical Jump Test than those who are insufficient or 
deficient. 
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The ancillary null hypotheses tested were: 
1) There will be no difference in vitamin D status based on subject’s vitamin D intake in 
collegiate athletes.  
2) There will be no difference in vitamin D status based on subjects sport. 
3) There will be no difference in vitamin D status based on subject’s gender in collegiate 
athletes.  
4) There will be no difference in vitamin D status based on subject’s ethnicity in collegiate 
athletes.  
5) There will be no difference in vitamin D status based on subject’s body composition (% 
fat) in collegiate athletes.  
Specific Aims  
The specific aims of this study are: 
1) To determine the incidence of vitamin D deficiency/insufficiency in a cross section of 
NCAA collegiate athletes.  
2) To explore the relationship between vitamin D status and muscular strength and muscular 
power by assessing specific functional performance measures, including Vertical Jump 
Test, Triple Hop for Distance Test, Shuttle Run Test, and 1 Repetition Maximum Squat.  
3) To explore the relationship between vitamin D status and muscular strength and muscular 
power by assessing specific calculated performance measures including power and force. 
4) To explore differences in vitamin D status based on vitamin D intake, sport, gender, 
ethnicity and body composition in NCAA collegiate athletes.  
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Definition of Terms 
1) Vitamin D Status 
Deficient- serum 25-OH D concentration at < 20 ng/mL.  
Insufficient- serum 25-OH D concentration 20- 30 ng/mL. 
Sufficient- serum 25-OH D concentration at > 30 ng/mL. 
Intoxication- serum 25-OH D concentration at ≥ 150 ng/mL; or complaints of signs and 
symptoms of fatigue, hypercalciuria and hypercalcemia.  
2) International Units (IU)- a unit of measure based on the available biological activity; 1 IU 
vitamin D is equal to 0.025 µg. 
3) Muscle Power- the ability to exert a rapid force (power = force*distance/time)41.  
4) Muscle Strength- amount of force a muscle can produce in a single maximal effort (force= 
power*time/distance)
42
. 
5) Incremental tests for peak power- increases in speed or workload until the point of 
exhaustion
41
.  
6) Iso-inertial tests- a single movement performed explosively against body mass. The measure 
of distance of height is the measure of power, using the mean of several trials
41
. 
Assumptions  
The assumptions of this study are: 
1) Subjects performed at maximal effort for each of the performance test.  
2) Subjects responded to the Food Frequency Questionnaire (FFQ) to the best of their ability.  
3) Subjects responded to the Calcium Questionnaire (CQ) to the best of their ability.  
4) Subjects responded to the Sun Exposure Questionnaire (SEQ) to the best of their ability. 
5) Subjects responded to the Health History Questionnaire (HHQ) to the best of their ability.  
6) Researchers conducted performance measures accurately.  
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Limitations  
The limitations of the study are: 
1) Researchers did not control for vitamin D status of participants.  
2) Data collection took place at several times of the year based on availability of subjects and 
may have biased vitamin D status. 
3) Participants may not have responded accurately to questionnaires. 
4) Participants may not have performed at their optimal level. 
Study Design  
This project utilized a cross-sectional study design to evaluate of the relationship between 
current vitamin D status and athletic performance measures of a subpopulation of NCAA collegiate 
athletes at The University of Tulsa (TU), Oklahoma State University (OSU) and Southern Nazarene 
University (SNU). Data such as health history, exogenous vitamin D (i.e., vitamin D from the diet), 
calcium intake, sun exposure, anthropometric and performance measures were collected to assess the 
effect vitamin D status has on the collegiate athlete.  
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
Historical Perspectives of Vitamin D 
  It is generally accepted that the need for vitamin D arose through evolution
43
. According 
to researchers in the field
4,43,44
, the sea was rich in minerals and provided the early vertebrates 
with adequate amounts of calcium for essential function. However, as these vertebrates began to 
migrate onto land, calcium became more sparse in the natural environment so these land dwelling 
creatures had to develop a new way to meet their daily need
43
. While it is still unknown how the 
relationship between vitamin D and sunlight evolved
44
, it is evident that vitamin D is essential for 
calcium homeostasis to maintain metabolic function
43
. It was not until society began to 
industrialize and experience less exposure to sunlight that the physiological requirement for 
vitamin D became apparent
45
.  
The Industrial Revolution was a time of change and advancement in Europe and the 
United States
46
. The push to move toward faster production of goods created jobs that existed 
inside factories and large warehouses
44
. The resulting decrease in sunlight exposure contributed to 
an epidemic of vitamin D insufficiency that went unrecognized until the mid-20
th
 century
25,46-50
. 
As a result of the lack of sunlight, and subsequently the rise of vitamin D insufficiency, rickets 
became one of the most debilitating diseases in children during this time
51
. The search for a cure 
for rickets stimulated the exploration of the health benefits of vitamin D
52
.
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From 1822, when the relationship between sunlight exposure and rickets was first 
discovered, until 1918 when exposure to sunlamps and administration of cod liver oil was shown 
to cure rickets, the functions of vitamin D were largely ignored by the public and for the most 
part, the scientific community
43,46
.  It was not until 1921, when researchers exposed several foods 
to irradiation as a cure for rickets, that vitamin D was considered a link to the disease
43,44,46
. Later, 
in 1926, Hess and colleagues, through animal studies and the irradiation of butter fat, discovered 
that cholesterol contained an impurity that proved to have antirachitic properties
53
. However, it 
was not until 1928, that vitamin D1 was identified
44
. In the mid-1930s the sources of vitamin D 
were recognized which resulted in the renaming of  vitamin D1 as vitamin D2 (i.e.,  plant sources) 
and vitamin D3 (i.e., animal sources)
44,54,55
. 
In the 1930s, an agreement was made between researchers in England, Germany and the 
United States, to isolate the cholesterol impurity and determine the sources of vitamin D
53
. 
Previously discovered in the late 1920s, this impurity had peak ultraviolet absorption between the 
ultraviolet wavelengths (UV) of 270-320 nanometers (nm)
53
. Windaus and Hess (1931) began 
their investigation on steroid compounds that had peak UV absorption within this range, leading 
to the detection and isolation of ergosteriol or vitamin D2
53
. However, this team of researchers 
knew that sunlight was the best way to achieve antirachitic doses of vitamin D, and ergosterol 
was not an animal source
56
. In 1935, Windaus and colleagues, isolated the cholesterol impurity, 
naming it 7-dehydrocholesterol (7-DHC) but it was not until 1937 that 7-DHC was identified as 
the precursor to vitamin D3 
53
.  
Today there has been a resurgence of rickets within society
51
. Less exposure to sunlight 
and greater vitamin D deficiency has become increasingly recognized by the allied healthcare and 
medical community as a major public health concern
44,57,58
; however, there is little congruity 
among medical professionals and researchers as to what constitutes deficient, insufficient, and 
sufficient concentrations of vitamin D as it relates to the overall health of an individual
59
.  
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Defining Vitamin D Status 
 The definition of vitamin D sufficiency, insufficiency, deficiency and intoxication has 
been an area of much debate
47,60
. Serum 25-OH D has been used as the basis for determining 
vitamin D status
42
, but there have been discrepancies in what physiological markers should be 
examined in determining serum 25-OH D, and therefore the definition of adequate 
concentrations
4
. Levis
61
 and Holick
4
, two well-known researchers in the field of vitamin D, have 
defined vitamin D deficiency as < 20 ng/mL, insufficiency at 21 ng/mL to 29 ng/mL, and 
sufficiency as ≥ 30 ng/mL, which are based on individual differences in parathyroid hormone 
(PTH) regulation. The American Medical Association (AMA) has defined deficiency as ≤ 10 
ng/mL and insufficiency at 11 ng/mL to 24 ng/mL
48
. In individuals with adequate 25-OH D, 
generally defined as ≥30 ng/mL, there is no disruption of optimal blood calcium concentrations 
by dietary calcium absorption or elevation in parathyroid hormone (PTH) regulation
44
. Vitamin D 
intoxication are not likely to occur until serum concentrations of 25-OH D are >150 ng/mL
4,61,62
.  
More recently there has been an interest by clinicians in determining optimal vitamin D 
status on an individual basis, using maximal calcium absorption and serum PTH levels as 
criteria
2,44,59,62
. Vitamin D insufficiency has a negative effect on calcium homeostasis, specifically 
leading to clinical secondary hyperparathyroidism, suboptimal calcium absorption, high bone 
turnover, and if the metabolic state persists, reduced bone mineral density (BMD)
63
. In contrast, 
vitamin D deficiency leads to clinical secondary hyperparathyroidism, malabsorption of calcium 
and osteomalacia
44,64
, while also exacerbating a number of health conditions, such as diabetes 
mellitus or osteoarthritis, which is linked to joint aches, muscle pain and overall 
weakness
33,61,63,65
.  
Prevalence of Vitamin D Deficiency and Insufficiency 
 An accumulating body of evidence has demonstrated that vitamin D deficiency and 
insufficiency is a major public health concern worldwide. The prevalence of vitamin D 
12 
 
insufficiency has been studied extensively on 5 of the 7 continents: Australia, Asia, Europe, 
Africa, and North America
66
. Australia has the highest occurrence of vitamin D insufficiency 
(i.e., 80% of the population), while in Asia 60%-70% of the population has inadequate serum 25-
OH D
66. Europe and Africa’s populations are both 50%-55% deficient in vitamin D while North 
America reported that 30%-40% of the population suffered from inadequate vitamin D status
66
. 
Some have characterized this state of vitamin D insufficiency a pandemic of all ages, including 
young adults
21,45,67,68
, older adults
3,4,44,69
, and youth
49,68,70
. Those populations at greatest risk of 
developing vitamin D insufficiency are individuals with limited sunlight exposure and low dietary 
intake of vitamin D
67
 and older adults in long-term care facilities
44
. 
 In young children and infants, rickets remains a public health problem in most developing 
countries
71,72
 as well as developed countries
51
. Factors that likely contribute to the high incidence 
of rickets are overcrowding, purduh (or complete covering of skin in Muslim women), a lack of 
access to sunlight and lack of vitamin D fortification of foods
51,71,72
. Schools in Australia require 
students to wear additional clothing during their lunch period, such as hats, long sleeves and pants 
to reduce the amount of sunlight exposure
38
. While decreasing the probability of skin cancers in 
the future, these practices are likely to increase future long-term fracture risk due to lower peak 
bone mineral density (BMD) at crucial periods of maturation
38
.  
Teenagers are another population at risk for vitamin D deficiency
48
. Wagoner and 
Greer
73
, demonstrated a significant increase in PTH and a decrease in 25-OH D occurred as 
children matured into adolescence. In the U.S., 17% of teenagers in the south that were tested in 
the winter months and 8% of the teenagers in the north that were tested in the summer months 
were vitamin D deficient
48
. Just as vitamin D concentrations tended to decrease from childhood 
into adolescence, the decline continues into adulthood
4
 
Several populations of older adults have been the subject of vitamin D research which 
examined the prevalence of inadequate vitamin D
74,75
. A study, conducted by Holick
4
 and 
colleagues, determined that 50% of postmenopausal women taking osteoporosis medication were 
13 
 
vitamin D deficient. Furthermore, MacDonald, et al
74
, found that 40% - 100% of community 
dwelling older adults were vitamin D deficient. In Europe, free living older adults (n=834) from 
16 towns in 11 countries were studied
76
. Thirty-six percent of males and 47% of females 
experienced vitamin D concentrations below 12 ng/mL
75,76
. In the United States, Meunier, et al
75
, 
found that vitamin D deficiency ranged from 3% to 28% in institutionalized older adults, but 
Gloth, et al
77
, reported as high as 54% of older adults living in long term care facilities were 
vitamin D deficient. The differences in prevalence of vitamin D deficiency among 
institutionalized older adults reported in literature can likely be attributed to differences in dietary 
intake
75
. 
Signs and Symptoms of Vitamin D Deficiency, Insufficiency and Intoxication  
 Commonly recognizable signs and symptoms of vitamin D insufficiency include bone 
frailty or fracture, resulting from an increase osteoclast activity and a decrease in BMD
64
. 
Chapuy, et al
78
, discovered that older ambulatory women experienced a 43% decrease in hip 
fracture and a 32% reduction in non-vertebral fracture when they were supplemented with 
calcium and vitamin D, verse those who were not supplemented. However, recent 
recommendations by the U.S. Preventative Services Task Force have brought the use of calcium 
and vitamin D supplementation (< 1000 mg calcium and < 400 IU vitamin D3) as a primary 
fracture prevention strategy into question
79
. Similarly, Fuleihan, et al
70
, studied school aged girls, 
who had deficient serum concentrations of 25-OH D (6 ng/mL to 22 ng/mL). The investigators 
discovered a significant correlation between BMD at the spine, femoral neck and radius and 
vitamin D status
70
. Other signs and symptoms of inadequate vitamin D include chronic kidney 
disease, generalized bone pain, myalgia, generalized weakness and hypocalcemia
46,80,81
.  Ladhani, 
et al
82
, showed that children (n = 17), with radiographic markings of rickets, experienced many of 
these signs and symptoms. In a study by Glerup, et al
33
, veiled Arab women complained of 
unexplained muscle pain (88%) and deep bone pain (36%) prior to vitamin D supplementation. 
14 
 
However, most of the women reported a decrease in muscle and bone pain after 1 to 1.5 months 
of 800 IU daily vitamin D supplementation, and the muscle and bone pain continued to decrease 
at 3 to 6 months post supplementation
33
.  
 Vitamin D is a fat soluble vitamin which means the potential for intoxication exist with 
mega doses (i.e., > 50,000 IU vitamin D weekly)
4,47
. Intoxication occurs when blood calcium 
homeostasis has been reached, but serum 25-OH D concentrations continue to increase in 
response to cutaneous synthesis or dietary intake
8
. With the accumulation of excess vitamin D, 
24-hydroxylase is unable to catabolize the metabolites of vitamin D (25-OH D or 1α,25-OH2 D) 
at a rapid enough rate
47
. Clinical signs of vitamin D intoxication include: an increase in urine 
calcium concentration, decrease renal function, and calcification of soft tissues (i.e., kidney, 
blood vessels, heart and lungs)
4,47
.  Hypersensitivity to vitamin D may be a concern in some 
individuals, such as those with chronic granulomatous, due to macrophage production of 1α, 25-
OH2 D which leads to hypercalciuria and hypercalcemia
4,62
. These persons should not avoid 
vitamin D consumption or the sunlight, but should be aware of their vitamin D status and 
maintain their status at the lower end of the normal range (i.e. 30 ng/mL)
62
.  
 Optimal serum concentrations of 25-OH D may differ by individual based on various 
parameters, such as ethnicity, age and sunlight exposure
66
. The need to agree upon definitions of 
deficient, insufficient, sufficient, and intoxication is essential in order to better identify 
individuals at risk for sub-adequate serum concentrations of vitamin D based on genetic or 
lifestyle factors
81,83
. 
Factors That Influence Vitamin D Status  
 Serum 25-OH D can be influenced by a number of factors
4
. These factors range from 
ethnicity, age and determinants of sunlight exposure, such as latitude and season of year
4,66
.   
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Ethnicity 
 Although vitamin D insufficiency is prevalent among most nationalities, skin 
pigmentation plays a major role in determining serum vitamin D concentrations
6,60
. Melanin in 
the skin serves as a natural inhibitor of cutaneous vitamin D synthesis
84
. Melanin competes with 
7-DHC for UV rays to produce skin color
85
. Chen, et al
86
 studied 4 human skin types to determine 
the effect melanin has on vitamin D synthesis. The investigators found that subjects with darker 
skin pigmentation required longer exposure to UV rays in order to reach and maintain serum 25-
OH D concentrations than fair pigmented subjects
86
. Similar the same sun exposure requirements 
were found by several researchers when examining different ethnic groups
8,45,87
.  
Research suggest that ethnicity may have an effect on vitamin D status
60
. Typically, non-
Hispanic/white populations have the highest serum 25-OH D and African, Caribbean, or African 
American have the lowest serum concentrations of 25-OH D when exposed to the sun for 
equitable lengths of time
6,26,57,60
.  Mithal, et al
88
, found that in the U.S., Caucasian Americans 
were less likely to have serum 25-OH D below the recommended range compared to populations  
of African American or Hispanic American origin. The researchers also stated that immigrants to 
Australia from the Middle East and Asia had serum  25-OH D concentrations less than native 
Australians and European Australians
88
. Bischoff-Ferrari, et al
60
, demonstrated that BMD was 
also highly correlated with culture and serum concentrations of vitamin D. The research team 
showed that in young adults (i.e., 20 – 49 years of age), BMD in vitamin D sufficient white 
individuals was 4.1% higher than vitamin D deficient African Americans
60
. By comparison, the 
BMD for vitamin D sufficient Mexican Americans and African Americans was 1.8% and 2.5 % 
higher than their respective vitamin D deficient counterparts
60
. These studies suggest that 
ethnicity is a determining factor in the vitamin D status of an individual as indicated by serum 25-
OH D as well as BMD.  
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Age 
 Age is another factor that influences the serum concentration of 25-OH D
69
. As people 
age the thickness of the skin begins to decrease, altering the its ability to initiate the synthesis of 
vitamin D in response to UV rays
85,89
. By the 7
th
 decade of life, most individuals will have 
experienced a 75% decrease in 7-DHC compared to young adults
62,65
. Therefore, vitamin D 
deficiency is a growing concern not only for senior citizens living in long-term care facilities, but 
also for older adults who are community-dwelling members of society
69
.  
In addition to the decrease in cutaneous synthesis of vitamin D with increasing age an 
inverse correlation has been demonstrated between the prevalence of nuclear vitamin D receptors 
(nVDR) and age
86
. The decrease in nVDRs in older adults was reported in a study performed in 
situ, of young and older adults undergoing back surgery
90
.  The young adult back patients had a 
higher number of nuclear VDRs in the muscle cell, as well as a higher serum 25-OH D 
concentration, compared to the older adults
90
. In a follow up to that study, Bischoff-Ferrari, et 
al
91
, determined that as individuals matured from adolescents into adulthood, a smaller quantity of 
VDRs were expressed in muscle cells. This pattern continued to decrease as they aged. These 
findings have lead researchers to postulate that genomic effects (i.e., muscle cell proliferation and 
differentiation) of vitamin D also decrease with age
86
. Fewer nuclear VDR and less 7-DHC in 
older adults may explain why even with adequate sunlight exposure, healthy older individuals 
often have suboptimal vitamin D status
67
. 
Sunlight Exposure 
    Exposure to the sun is the greatest source of vitamin D for humans
25,56. In today’s 
society, the average person wears clothing that covers all but 5% of their body; defined as the 
face, hands and arms
8,14,48,89
 . In people with fair, light-skinned pigmentation, exposing 5% of the 
body to sunlight for 5 minutes 2 to 3 times per week during the summer can produce up to 400 IU 
of vitamin D daily
8,14,89
. Levis
61
 and colleagues reported that people who lived in sun rich 
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environments maintained serum 25-OH D status between 40 ng/mL and 65 ng/mL. In addition to 
skin pigmentation
48,68
 and sun exposure
92
, there are several other factors that inhibit the sun’s 
effectiveness to promote vitamin D synthesis in the skin, including latitude
8,46,61
, season of the 
year
49,93
, adipose tissue
14,50,68
. 
 Latitude is a major determinant of endogenous vitamin D synthesis and therefore, 25-OH 
D serum concentrations
46,61
. For vitamin D to be synthesized in the skin, the sun must emit 
wavelengths of 270-320 nanometers (nm)
43,57,94
. The UV wavelength may be altered by factors 
such as time of day, atmospheric interference (e.g., pollution and cloud cover), and the distance 
between the Sun and Earth’s surface67,85. When considering these complexities, UV waves 
available to reach human skin for vitamin D production are limited
57
. At extreme latitudes (35° N 
or 35° S), very few UV rays are at the appropriate wavelength for vitamin D synthesis to occur 
year round
57
. Boston, which is located at 42°N, has sunlight that is unable to sustain cutaneous 
vitamin D synthesis between November and February. North of Boston (i.e., 310 miles) in 
Edmonton, Canada, non-vitamin D producing sunlight is emitted between October and March
64
. 
In France, two general urban adult populations were tested in the north (51° N) and in the south 
along the Mediterranean Coast at 43°N
92
. The populations tested in the northern communities 
were 31% insufficient while 7% of the people in the south were insufficient
92
. In sunny areas of 
the world such as Milan, the Mediterranean and the Middle East, compromised vitamin D status 
may be attributed to heightened awareness of skin cancer, which leads to greater use of sunscreen 
or avoidance of the sun
61
.  
Healthy young adults, older adults and children have all shown fluctuations in serum 
concentration of vitamin D by season of the year
49,93
. During the winter months, the angle at 
which UV rays strike the Earth’s surface change37. Due to the alteration of the zenith angle, the 
UV rays are not able to reach the critical wavelengths needed to promote cutaneous vitamin D 
production
37,57
. This is evident in Northern Italy (45°N),  where 57% of older adult women were 
deficient during the months of December through May and 17% were deficient June through 
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November
64
. Of children studied in the winter months in coastal northern Spain (43°N), 80% had  
serum 25-OH D concentrations lower than 20 ng/mL, and in the summer the average 
concentration increased to 29 ng/mL
49
. In Europe, plasma vitamin D varied greatly based on 
region, but in all countries subjects had higher concentrations of 25-OH D in the summer 
compared to the winter
93
. In the U.S., Florida’s community-dwelling older adults demonstrated 
similar results as the previous two studies, with subjects having greater serum concentrations of 
vitamin D in the summer
61
.  
The wavelengths of the sun are not the only natural inhibitor of endogenous vitamin D 
production
14
. Subcutaneous adipose distribution has also been shown to affect serum 25-OH D in 
adolescents
14
 and adults
50
. Vitamin D and 7-DHC can be sequestered in adipose tissue which 
decreases the bioavailability of active vitamin D
25,50
.  Studies by Zamboni, et al
25
, and Snijder, et 
al
50
, reported that the more subcutaneous adipose tissue an individual had, the lower the vitamin 
D status. Gilsanz, et al
21
, found that higher concentrations of intramuscular adipose tissue 
correlated with a greater degree of vitamin D insufficiency. When compared to women with 
sufficient vitamin D status, women that were vitamin D insufficient had 24% greater 
intramuscular adipose deposits
21
. At this time, additional research is needed to determine the 
extent in which adiposity affects vitamin D status to inform dietary recommendations for vitamin 
D intake
21
.  
Dietary Recommendations for Vitamin D 
 While sunlight and irradiated foods are sources of vitamin D, the IOM reviewed and 
established the Dietary Reference Intakes (DRI) for vitamin D
7
. In November 2010, an IOM 
panel was convened to review the Recommended Daily Intake (RDA) for vitamin D and calcium, 
which had been set in 1997, to determine if the DRI needed to be revised based on more recent 
data
7
. The committee found that changes to the vitamin D RDA were prudent. The concluded 
there was unsatisfactory evidence to support claims of any additional health benefits aside from 
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those benefits associated with skeletal health and that further research was needed
7
. The current 
IOM recommendations are shown by age group in Table 1. 
 
 
EAR= Estimated Average Requirement; RDA=Recommended Dietary Allowance; UL= Upper Limit 
 
The IOM recommendations were made on the basis that most of the American and 
Canadian public are receiving minimal sun exposure and experiencing normal blood calcium and 
low to normal fasting serum phosphorus
7
. The committee also found that most individuals have 
serum 25-OH D concentrations above 20 ng/mL, which is needed to maintain bone health; 
however, the same population was consuming less than the Estimated Average Requirement 
(EAR)
7
. These findings suggested that the sun exposure requirement was being met, limiting the 
amount of vitamin D needed through dietary and supplementation sources
7
.  
Following the 2010 IOM recommendations, several researchers expressed that the 
recommendations were too low to meet the daily requirement of the general populations. Dong, et 
al
95
, reported that after 16 weeks of supplementation at 2,000 IU per day, African American youth 
increased an average of 34 ng/mL. Heaney and Holick released a commentary stating that the 
new recommendations disregarded all research on the non-skeletal benefits of vitamin D and that 
the science does not support that bone health can be maintained at a serum 25-OH D 
concentration of 20 ng/mL, as the IOM had claimed
96
. In a 2012 commentary by Heaney
59
 the 
issue of defining vitamin D status in response to the IOM report was addressed. He stated that 
Table 1. Dietary Recommendations of the Institute of Medicine for Vitamin D 
7
  
Age Groups 
 EAR  
(IU) 
RDA  
(IU) 
UL   
(IU) 
Birth to 6 months N/A N/A 1,000 
6 to 12 months N/A N/A 1,500 
1 to 3 years  400 600 2,500 
4 to 8 years 400 600 3,000 
9 to 70 years 400 600 4,000 
70 years and older 400 800 4,000 
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current research had treated vitamin D intake as a medication and adopted the Evidence Based 
Medicine model. He argued that instead vitamin D should be treated as a nutrient, using an 
Evidenced Based Nutrition model to conduct research
59
. Heaney
59
 also identified several key 
factors that make this type of research difficult to consider in the traditional medical model, such 
as: 1) subject specific dose response curves, 2) ethical dilemma in placing a deficient control 
group on low dose supplementation, and 3) the feasibility of a zero-intake control group. He 
concluded that until a solution for these issues is found, it will prove difficult to accurately define 
insufficiency, deficiency and sufficiency
59
. In order to conduct evidence based nutrition research, 
it is important to have good understanding of the food sources of vitamin D
96
. 
Food Sources of Vitamin D 
 Very few foods naturally contain vitamin D
9,47,94
. It is most commonly found in fish oils, 
cod liver oil, fatty fish (salmon, mackerel, sardines) and eggs
94,97
 (Table 2). Due to the limited 
number of natural sources of vitamin D and the rickets epidemic of the Industrial Revolution, the 
United States, United Kingdom and Canada began to fortify foods such as dairy and grains
45,61
. In 
theory, fortification of vitamin D subsidized what was lacking in the diet, however, there has been 
no consensus among experts in the field as to the amount of vitamin D supplementation and 
fortification that was optimal
47
. Today, fortified dairy sources include milk 
 
 
 
 
 
 
 
 
21 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and yogurt, while non-dairy sources include orange juice, breads and cereals
45,56
. Approximately 
98% of all fluid milk is fortified with 100 IU for every 8 ounce serving of milk
56,94
. In a study 
examining the correlation between dietary intake of fortified foods and serum 25-OH D 
concentrations, healthy adolescent subjects displayed an increase in serum 25-OH D with greater 
consumption of milk and cereals and decreased serum concentrations with juice and soft drink 
consumption
68
. However, with the increasing incidence of reported lactose intolerance, fortified 
dairy foods may be avoided, leading to an inconsistency of vitamin D dietary intake
48
. Therefore, 
over-the-counter multivitamins and single vitamin supplements can provide an alternative source 
of vitamin D for these individuals
47,68
 
Table 2. Dietary Sources of Vitamin D
94
   
Food Serving Size Vitamin D (IU) 
Cod Liver Oil 1 Tbsp 1,360 
Wild Salmon 3.5 oz 981 
Sun Dried Shiitaike Mushrooms 1 oz 400 - 500 
Canned Sardines 3.5 oz 270 
Farmed Salmon 3.5 oz 249 
Tuna Ahi 3.5 oz 164 
Milk, Fortified 8 oz 100 
Orange Juice, Fortified 8 oz 100 
Cod 3.5 oz 80 
Yogurt, Fortified 4 - 6 oz 8 - 80 
Margerine, Fortified 1 Tbsp 60 
Kraft 2% Milk Singles (American) 1 slice 40 
Cereal, Fortified 3/4 - 1 cup 40 
Egg Yolk 1 18 
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Supplementation of Vitamin D 
 Due to the limited food sources and the many inhibitors to cutaneous synthesis of vitamin 
D, supplementation has become a popular means of attaining adequate vitamin D status
49,52,92
. 
However, knowledge of an individual’s current serum 25-OH D and supplementation practices 
are essential to ensure sufficient vitamin D status is maintained
43
. 
 The current RDA for adults (i.e., 9-70 years of age) is 600 IU per day
7,47,67
. Based on 
previous recommendations, Chel, et al
52
, showed that 200 IU per day was enough to maintain 
current serum 25-OH D in older adults, but would not increase serum vitamin D. However, 
Chapuy, et al
92
, reported that while 200 IU maintained current concentrations of serum 25-OH D, 
it should be considered inadequate for young adults due to a decrease in the time spent outdoors, 
poor dietary habits and general maturation. Docio, et al
49
, showed that adults living in South 
Florida, 97% were vitamin D deficient while supplementing greater than 200 IU per day. It has 
been estimated that for every 100 IU of  vitamin D consumed, plasma concentration status 
increases 1 ng/mL
43
.  While supplementation has been shown to be effective in increasing serum 
25-OH D concentration, caution should be taken when supplementing vitamin D to avoid 
intoxication
47
. 
 Intoxication from supplementation has most often been reported in individuals who 
consumed large doses of vitamin D for short periods of time
52
. The tolerable upper limit (UL) is 
the amount where there is no potential risk for harm
9
. To ensure safety, an individual assessment 
of 25-OH D is required
47,56,60
. Table 3 compares the Institute of Medicine and reviewed literature 
recommendations for adequate vitamin D supplementation to maintain a sufficient serum 25-OH 
D concentrations in individuals who are at increased risk for inadequacy. 
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Table 3. Comparison of the IOM and Reviewed Literature Recommendations for Vitamin 
D Supplementation of Persons 9-70 Years of Age 
 Deficiency 
(osteomalacia) 
Insufficiency 
(osteoporosis) 
Sufficiency Desirable 
(Optimal Ca Absorption) 
Institute of 
Medicine 
Recommendation 
 
0 IU 
 
200-400 IU 
 
200-600 IU 
 
Not Stated 
 
Proposed Expert 
Opinion
45
 
 
200 IU 
 
400-600 IU 
 
1,000-4,000IU 
 
4,000-10,000 IU 
 
Inhibitors of Vitamin D Bioavailability  
 The examination of the pharmacokinetics of vitamin D has been difficult for 2 reasons: 1) 
vitamin D is stored in tissues that are located throughout the body (i.e., adipose and muscle); and 
2) humans are never fully deprived of vitamin D
98
. Animal studies have provided the opportunity 
to study the pharmacokinetics of vitamin D in vivo by controlling these conditions
98,99
. Lawson, et 
al
99
, exposed rats to artificial UV rays and measured 25-OH D at various time points post 
exposure. They found that adipose stores contain the largest pool of vitamin D
99
. However, only 
5% was recoverable to be hydrolyzed to 1α,25-OH2 D and, 95% of cutaneous vitamin D failed to 
be activated by hydroxylation and was lost through urinary excretion
99
. Furthermore, only 25% of 
the vitamin D consumed through diet or supplementation was hydrolyzed to 25-OH D in the 
liver
98
, and the remaining 75% was catabolized by 24-hydroxylase in the kidney and 
excreted
98,100
.  
Another factor in the bioavailability of vitamin D was the pharmacological half-life of 
serum 25-OH D, which ranged from 10 to 21 days
98
. In contrast, the half-life of vitamin D stored 
within subcutaneous fat or muscle cell increases to 30-60 days
43,46
. A study conducted by Preece 
and colleagues
101
 compared the baseline and final serum 25-OH D of submariners after a 2 month 
tour with little access to vitamin D fortified foods and no vitamin D supplementation. They 
discovered that the serum concentration of the submariners decreased 50% during the 2 month 
time period, supporting the idea that vitamin D status declines in absence of sunlight, and the 
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body must rely on stored vitamin D
98,101
. This study supports the biological half-life and endorses 
that in most individuals, inadequate levels of 25-OH D may be observed in as little as 2 months, 
depending on the individuals vitamin D status when adequate dietary intake of vitamin D 
ceased
63,102
.   
Metabolism of Vitamin D 
 The two primary sources of vitamin D include cutaneous synthesis and dietary intake. 
Once vitamin D enters the circulation, the metabolism is somewhat complex and involves several 
hydroxylation and isomerization reactions as it progresses from previtamin D to a biologically 
active hormone
43
.  
Cutaneous Synthesis of Vitamin D 
Cutaneous synthesis of vitamin D, whether by natural sunlight or artificial sun lamps, 
begins though photochemical isomerization of 7-DHC located in the phospholipid bilayer of the 
of the epidermis
43,56,87
. Holick, et al
103
, demonstrated that 65% of 7-DHC is found in the 
epidermis of the skin, while the remaining 35% was located in the dermis. 7-DHC contains a 
chromophore that absorbs the UV (280-320 nm), initiating isomerization from 7-DHC to pre-
vitamin D
43
. Havinga
104
 revealed that the isomerization from pre-vitamin D to vitamin D was not 
affected by acids, bases, or catalyst, but was a temperature dependent isomerization (i.e., ambient 
air temperature at 77°F) within the epidermal layers of the skin. After Vitamin D’s temperature 
dependent isomerization, vitamin D3 is translocated into the dermal layer of the skin
43,45,87
, 
followed by subsequent diffusion into the blood
94
. Approximately 60% of cutaneous vitamin D 
binds to vitamin D binding protein (DBP) to be taken to the liver for hydroxylation to 25-OH D 
or delivered to the muscle or adipose tissue to be stored
94
. Prolonged over exposure of cutaneous 
vitamin D to sunlight, can result in the reversible formation of luminsterol and tachysterol, or can 
result in the irreversible formation of toxisterol
43,87
 (Figure 1). When sun exposure is not 
available, the body must rely on diet to maintain adequate vitamin D serum concentrations
8
.  
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Absorption of Dietary Vitamin D 
Metabolism of dietary vitamin D is crucial for the absorption and transport of the fat 
soluble vitamin
105,106
. Large, particles containing fat soluble vitamins are collected at the 
enterocyte, located in the wall of the small intestine, where a carbohydrate is added to form a 
chylomicron
106
. The chylomicron, consisting of triglycerides, cholesterol, fat soluble vitamins (~ 
40-60% of dietary vitamin D) and phospholipids, is transported to the cell membrane and 
exocytosed into the lymphatic system where it is diffused into the circulatory system
106
. 
Chylomicrons are transported through the serum, where they undergo lipolysis by lipoprotein 
lipase. Chylomicrons release free fatty acids and diglycerols into cells, leaving only a 
Figure 1: Cutaneous Synthesis of Vitamin D45 
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chylomicron remnant
105
. During the breakdown of the chylomicron by lipases, vitamin D may be 
released by the chylomicron to a DBP to travel to muscle tissue or adipose tissue for storage
105
. 
Some chylomicron remnants may transport vitamin D to the liver for hydroxylation to 25-OH 
D
105
.  
There are many known factors that can interfere with vitamin D absorption, including 
certain hormones and disease
107
. However, the literature is conflicting in describing the extent and 
effect each element has on vitamin D and its metabolites
47
. Hormones such as PTH, estrogen, and  
testosterone can increase vitamin D absorption in the gut while growth hormone and thyroid 
hormone are known to decrease the absorption of vitamin D107. Bouillon108 described various 
diseases that can also have a negative effect on vitamin D status, such as renal disease or liver 
diseases. Liver failure can lead to vitamin D malabsorption; while liver disease and kidney 
disease lead to a decrease in hydroxylation of vitamin D metabolites
108
. Regardless of the source 
of vitamin D, to become biologically active it must undergo a series of hydroxylation reactions
43
.  
Hydroxylation of Vitamin D to Biologically Active Forms  
 Vitamin D, bound by DBP and transported through the circulatory system to the liver, is 
enzymatically hydroxylated by 25-hydroxylase within the endoplasmic reticulum or 27-
hydroxylase within the mitochondria of hepatocytes
109
. In a meta-analysis, Holick, et al
43
 showed 
that the hydroxylation from pre-vitamin D to 25-OH D is not controlled by vitamin D or calcium 
status
43
, nor does it favor endogenous or exogenous vitamin D sources
109
. Rather it is controlled 
by release of PTH from the parathyroid gland
110
, which stimulates the release of 25-OH D from 
the liver into the circulatory system, bound by DBP
94
. 
 The DBP transports 25-OH D to the kidney to be further activated by 25-hydroxyvitamin 
D1α-hydroxylase43,94, resulting in 1α,25-OH2 D
9,43,56
. This hydroxylation reaction is slower than 
the reaction catalyzed by 25-hydroxylase
43,47,64
. The process is regulated by PTH in response to a 
change in serum calcium
43,47,64
. Takeyama and Kitanaka
111
 used knockout mice to demonstrate 
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that the 25-hydroxyvitamin D1α-hydroxylase reaction does not occur in any other tissues, but the 
kidney and, most notably in the proximal tubule
111
. Once 1α,25-OH2 D leaves the kidney, DBP 
again transports the metabolite to target tissues throughout the body for interaction with either the 
membrane-bound VDR (mVDR) or genomic VDR (nVDR)
43,65
. If serum 25-OH D concentrations 
for an individual are sufficient, then 25-OH D is catabolized by 25-hydroxyvitmain D24-
hydroxylase in the distal renal tubule
43,112. This hydroxylation allows 1α,24,25-OH3 D to enter the 
C24 Oxidation Pathway, converting the vitamin D metabolites from hydrophobic to hydrophilic 
units and excreted through the urine
43,112
 . 
Vitamin D Receptor 
 The biologically active form of vitamin D, 1α,25-OH2 D functions as a hormone. With 
the aid of transport proteins, it moves through the cell membrane to the membrane bound vitamin 
D receptor (mVDR), or travels through the cytosol to the nuclear vitamin D receptor 
(nVDR)
28,74,113,114
. Through a series of protein interactions, the VDR binds with the nuclear 
membrane
43
, where it forms a heterodimer with retinoid-x receptor (RXR) resulting in a 
transcription of vitamin D response elements (VDRE)
43,74,113
.  
VDR possesses the ability to produce genomic or non-genomic effects
28,113,115
. Genomic 
effects are mediated by the nVDR, while non-genomic effects are mediated by the mVDR
28,43
. 
Genomic actions are generated through a slower pathway and are activated by gene 
transcriptions, which have been shown to generate responses in as many as 30 identified target 
tissues
28,113
. Non-genomic effects are described as rapid responses and cannot typically be 
explained by the activation of slower genomic gene transcriptions
28,113
. These genomic and non-
genomic events that are mediated by vitamin D result in 1α,25-OH D functioning in a variety of 
physiological processes, including muscle function
43
. 
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Muscle Function and Vitamin D 
Vitamin D is essential for maintaining muscular calcium homeostasis
28,116
 and 
neuromuscular function
28,61
. Muscle fibers contain VDRs that, when activated by their ligand 
1α,25-OH2, functions as a steroid hormone and contributes both genomic and non-genomic 
effects 
116,117
. Genomic effects include increased synthesis of various cytoskeletal proteins that: 1) 
regulate calcium movement within the cell (e.g., calmodulin and calbindin D-9K); 2) induce 
hypertrophy (insulin-like growth factor) and; 3) control remodeling of the muscle cell surface 
(e.g., tyrosine kinase)
28,65,118. Genomic effects of 1α,25-OH2 D also include increased phosphate 
metabolism and the regulation of muscle cell proliferation and differentiation due to mechanisms 
unrelated to calcium
28
. In vitamin D deficient or insufficient individuals, these functions may be 
seriously compromised before classic signs of bone loss or severe deficiency appear 
clinically
33,61,116
. For instance, a decline in muscle strength has been associated with serum 25-OH 
D concentrations at or below 30 ng/mL in the older adult population
65
. However, as serum 
concentration of 25-OH D improve, lower extremity functions improve as well
33,67
. Currently, 
three working theories have proposed that vitamin D status improves muscle function by: 1) a 
1α,25-OH2 D mediated increase in the rate of the excitation-contraction mechanism by enhancing 
calcium re-uptake from the sarcoplasm to the sarcoplasmic reticulum 2) the VDR in striated 
muscle cells target 1α,25-OH2 D, increasing phosphate transport, and 3) increasing cell 
proliferation and differentiation through genomic effects
28,31
. 
Vitamin D’s Role in Calcium Re-Uptake from the Sarcoplasm  
 To improve muscle contraction, cellular calcium homeostasis must be maintained
119
. 
Intracellular calcium concentrations can be altered by voltage-dependent (non-genomic) and 
ligand binding (genomic) mechanisms
28,45
. Vitamin D dependent calcium binding proteins, 
calmodulin and calbindin D-9K, located on the cell membranes and endoplasmic reticulum 
membrane, bind to the calcium ions and stimulate conformational changes and alterations in cell 
29 
 
function
28,119
. Upon binding to these calcium binding proteins, protein kinase C (PKC) is 
activated which in turn stimulates an influx of extracellular calcium from the store operated 
calcium channels (SOCC)
28
. 
1α,25-OH2 D is essential for intracellular calcium movement during a muscle 
contraction
120
. In the resting state, muscle fiber intracellular calcium is located in the terminal 
cisternae of the sarcoplasmic reticulum
121
. These cisterna have a series of calcium voltage-gates 
calcium channels, calcium induces-calcium release channels and an ATP dependent Ca-ATPase 
pump
121
. As the action potential travels down the T-tubules, the sodium/calcium channels and 
calcium voltage-gated channels open, allowing the calcium to enter the cell
45,122
. This increase in 
intracellular calcium causes the calcium induced-calcium release channels of the sarcoplasmic 
reticulum membrane to release large amounts of calcium into the sarcoplasm
45,121
. Animal models 
of vitamin D deficiency have shown that when the excitation-contraction cycle is inefficient 
calcium turnover in the muscle is poor
31
. The proposed mechanism by which this phenomenon 
occurs is a result of increased relaxation time or the availability of free calcium ions
31
. In vitamin 
D deficient animals, the release of troponin C from actin is delayed
33,65,123
 and time to relaxation 
of the fibrils is prolonged
33,65
. This increase in relaxation time resulted in less tension of the 
muscle fibers, and overtime, decreased strength during a contraction
123
. Rodman, et al
124
, 
demonstrated that peak tension and recovery to a resting state was delayed in vitamin D deficient 
rats and this response was not related to serum calcium or phosphate but could be reversed with 
the administration of 1α,25-OH2 D. By exposing vitamin D depleted skeletal muscle to 1α,25-
OH2 D, in vitro, calcium uptake significantly increased
30,31,117,118
, especially when vitamin D was 
administered in short intervals
117,118
. Vitamin D has been shown to increase the function of 
sarco(endo)plasmic reticulum calcium adenosine triphosphate-ase (SERCA)
29,33,65
, an enzyme 
that transfers calcium from the sarcoplasm to the sarcoplasmic reticulum during muscle 
relaxation
125
.  
Figure 4: Regulation of Intracellular calcium movement by 1α,25-OH2 D (Hazell) 
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Another mechanism by which vitamin D influences the excitation-contraction cycle is by 
the number of free calcium ions available in the sarcoplasmic reticulum
123
. Calcium influx in 
vitamin D deficient animals was shown to be partly regulated by G-protein
126
. However in 
vitamin D sufficient muscle, calcium influx was regulated by protein kinase C and protein kinase 
A, which can activate the voltage-gated calcium channels and, increase calmodulin binding for 
intracellular calcium movement
35,120,126
. Vitamin D activation by this non-genomic mechanism
118
 
stimulates the transport of calcium which produces a greater excitation-contraction cycle
31
. 
Vitamin D Role in Phosphorus Regulation   
 The most readily available energy system that is most often associated with power 
production is the phosphocreatine system (ATP-CP)
125,127,128. 1α,25-OH2 D and 25-OH D increase 
phosphate uptake in the muscle cells
126
, suggesting that vitamin D may play a role in ATP 
synthesis in the ATP-CP system
29,33,65,129
. Inorganic phosphate is considered the rate limiting 
factor for ATP synthesis
129
. The sodium-phosphate co-transporter enzyme that is responsible for 
phosphate reabsorption from the renal tubules is also present in the membranes of myocytes
126
. In 
vitamin D depleted animals, the ATP-CP system failed quickly, but supplementation of vitamin D 
prolonged the use of ATP-CP metabolism
31
 making the amount of inorganic phosphate in the 
muscle cell, the first indication that proper vitamin D concentration had been reached
129
. 
 More recently, research has focused on ATP-dependent calcium uptake by the 
sarcoplasmic reticulum, as well as normal phosphorus fluctuation across the sarcolemma
28,32
. 
While the correlation between the 1α,25-OH2 D and ATP-dependent calcium uptake is not clear, 
some investigators have proposed a mechanism involving the activation of FGF-23
28
, which 
increases the accumulation of phosphorus within the cell
28,32
. However, further investigation into 
the mechanism of the increase of phosphorus by FGF-23 is warranted
32
.  
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Vitamin D’s Role in Muscle Cell Proliferation and Differentiation  
Not only does vitamin D play an important role in calcium homeostasis in the 
sarcoplasmic reticulum and in phosphorus metabolism, but it is also important for myoblast 
proliferation which aids in hypertrophy of the muscle
29,33,65,126,129
.  The binding of 1α,25-OH2 D to 
the VDR leads to the dephosphorylation of c-Src, a tyrosine kinase protein
28
. The 
dephosphorylation of c-Src stimulates the phosphorylation of several families of the mitogen 
activated protein kinase (MAPK)
28,32
, resulting in a cascade of transcription factors regulating cell 
growth and differentiation
28
. 
Muscle myopathies, as well as atrophy, are common in vitamin D deficient individuals
126
. 
Sorensen
130
 found that supplementation of 400 IU 1α,25-OH2 D and 500 mg calcium for 3 to 6 
months increased Type II muscle fiber area. Moreover, Sato
131
 found that supplementation of 
1,000 IU vitamin D alone for 2 years increased type II muscle diameter and percentage within the 
muscle composition. Research conducted by Ceglia and Sorensen confirmed these findings
130,132
. 
At this point it is not clear which of the proposed mechanisms or combination of mechanisms 
explains the relationship between vitamin D status and muscle function
28
. Further research is 
needed to determine how vitamin D serum concentrations has a potential to impact muscle 
strength and power
32
.  
Vitamin D and Muscle Strength and Muscle Power  
Muscle strength and power are essential for activities of daily living
65
. Adequate vitamin 
D status has been associated with increased gains in muscle function in a variety of age groups 
and populations ranging from the adolescent to the older adult
65
. In contrast, low serum 
concentrations of 25-OH D are associated with compromised muscle function and increased 
disability
25
.  
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Muscle Strength and Muscle Power in the General Population 
 Adolescents to older adults have been studied to understand the relationship between 
vitamin D status and muscle function
18,69
. Visser, et al
69
, reported that older adults with < 25 
ng/mL serum 25-OH D were at a greater risk for sarcopenia based on grip strength and muscle 
mass compared to a control group of vitamin D sufficient older adults. Crocombe and Mughal
133
 
evaluated 8 case studies over a 5 year period, and concluded that older adult subjects were unable 
to stand unassisted from a squat position or ascend stairs due to myopathy. In post-menarchal 
adolescent girls who were suffering from muscle weakness, poor vitamin D status was associated 
with a decrease in muscle strength, power and endurance
18
. Girls with low vitamin D serum 
concentrations (11.6 ng/mL) had lower vertical jump height, velocity of jump, level of fitness and 
generated force production
18
. Despite the low levels of serum 25-OH D, none of the girls 
exhibited clinical signs and symptoms of vitamin D insufficiency
18
. The measures of muscle 
performance used in that study have also examined muscle fiber type
65
.   
 In the general population, muscles that  have the greatest effect on muscle strength and 
power are mainly composed of Type II muscle fibers (i.e., fast twitch muscle fibers)
65
. Pfeifer, et 
al
65
, demonstrated that the relationship of vitamin D serum concentration to muscle strength 
depended on the type of muscle fiber that was targeted. Latham, et al, showed that in frail older 
adults, biopsies of Type I muscle fibers (i.e., slow twitch fibers) revealed no change in activities 
of daily living (ADLs) with supplementation of a single dose of 300,000 IU of vitamin D
134
. 
Other studies found that type II muscle fibers were associated with power and have a significant 
effect on muscular function
18,25,26,116,134
. It has been proposed that the sarcoplasmic reticulum of 
type II muscle fibers is more developed than Type I muscle fibers, allowing Type II to transport 
calcium in and out of the sarcoplasmic reticulum at an increased rate
127
. Type II muscle fibers 
without exposure to adequate vitamin D, as shown through animal models, exchange calcium 
similar to Type I muscle fibers
65
. These studies provide evidence that supplementation of vitamin 
D may result in higher serum 25-OH D concentrations and affect muscle strength and power
116
.  
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The Effect of Vitamin D Supplementation on Muscle Strength and Muscle Power  
 Supplementation of vitamin D not only has varying effects based on muscle fiber type, 
but is also specific to muscles based on anatomical location
65
. Lower serum concentrations of 25-
OH D in subjects resulted in a greater loss of appendicular muscle mass
69
. Lower extremity 
muscle function increased the most when subjects’ serum concentrations were in the range of 35 
ng/mL - 40 ng/mL
26
. The most pronounced effects were observed in the muscles responsible for 
lower extremity power, such as the quadriceps and gastrosoleus complex
18,33,60,134,135
.  
In the older population, muscle strength and muscle power of the lower extremity was 
assessed by the number of falls over a period of time or by balance
4,26,35,52,69,134
. Studies showed 
that in older adults supplemented with vitamin D (800 IU), the number of falls decreased, leading 
the researchers to conclude the vitamin D specifically improves lower extremity musculoskeletal 
function
116
. Saadi, et al
63
, tested vitamin D status in older women and found that low levels of 25-
OH D were associated with a decrease in walking ability and increase in falls. Two other studies 
reported a decrease in upper and lower extremity strength associated with low levels of 25-OH 
D
25,69
. Much research has demonstrated that in both independent and dependent-living senior 
citizens vitamin D status can affect muscle strength and power, however, little research has been 
done to determine the effect of vitamin D status on muscle strength and power in athletes
18,70
.  
Vitamin D Status and the Relation to Athletic Performance  
 Power can be defined as force multiplied by the shortening velocity of the muscle
136
. In 
gross anatomy, force is most manipulated by movement requiring a high force output such as a 1 
repetition maximum (1 RM), and shortening velocity is influenced by speed movement such as 
jumping
136
. This phenomenon, known as the force-velocity relationship, states that as the velocity 
of the shortening muscle increases, less actin and myosin cross bridges attach, decreasing the total 
force produced
137
. The opposite holds true for a muscle which is shortening at a slower velocity 
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(i.e., more cross bridges attach, increasing force production)
137
. However, power can also be 
influenced by both metabolic and ionic changes that occur within the cell
136
.  
 Vitamin D’s contribution to athletic performance can also be found in performance 
outcomes of muscle power and strength
39
. Several studies from Germany and Russia in the early 
to mid-20
th
 century, examined the effects of pre-competition sun lamp treatments on elite 
athletes
37,39
. In 1927, Germany tested the effectiveness of sun lamps on swimmers before their 
competition and found that swimmers had decreased split times
39
. Results of this study were 
conveyed to the German Olympic Committee and the practice of using sun lamps prior to 
competition was prohibited; termed as “doping” for performance enhancement39. Similarly, in 
1930, Russia tested the effect of sun lamps on 100 meter sprinters noting an improvement in 
speed as high as 7% over their baseline speed
39,138
. In the mid-1940s, Germany and the United 
States continued research focused on vitamin D status and performance as it related to 
endurance
136,139
. Both countries, using non-athletes, reported an increase in cardiovascular 
endurance on the bike ergometer
136,138
. Germany continued with vitamin D research and , in the 
1950s began to supplement children with high doses of vitamin D to determine if 
supplementation was as effective as sun lamps
140,141
. The first of these studies put sun lamps in a 
classroom of school children to see what improvements were made in athletic performance
140
. In 
a subsequent study, this research team supplemented a separate classroom of students with 
250,000 IU of vitamin D
141
. They concluded that 3 months post-supplementation both classrooms 
of school children had comparable levels of improved athletic performance
141
. During this same 
time period, Germany again began using sun lamps on their elite athletes to improve 
performance
142
. The last known study to correlate ultraviolet irradiation through the use of sun 
lamps to improve performance was in the United States in the 1960s
143
. A single dose of 
irradiation was given to the collegiate non-athlete women, which resulted in an increase in 
strength, speed and endurance
143-145
. These researchers concluded that exposure to irradiation can 
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improve muscle performance in young adults; however, this research did not incorporate any 
investigation into other lifestyle factors that may have contributed to this phenomenon
143
.  
Due to the collegiate lifestyle and dietary habits, most college athletes do not meet with 
RDI of vitamin D
11,146
. Athletes who train and compete indoors year round or use sun block while 
practicing outdoors may never achieve adequate levels of vitamin D
34,37,39
. Several studies have 
conducted cross sectional analysis of vitamin D serum concentrations in a variety of 
athletes
36,37,39
.  For instance, Rankinen, et al
147
, concluded that Finnish male ski jumpers had 
inadequate vitamin D status due to low dietary intake of all nutrients, a consequence of the sport 
(Table 4). A year later in 1999, Lehtonon-Veromaa, et al
36
, found that Finnish gymnasts and 
runners when compared to controls, were just as likely to be vitamin D insufficient, with 11.3% 
of those studied having serum 25-OH D below 30 ng/mL (Table 4). The research team also found 
that vitamin D intake was low, even though they were meeting the RDA of most other 
micronutrients. Lovell
38
 completed a similar study on elite adolescent gymnasts. He discovered 
that the athletes averaged 22 ng/mL serum 25-OH D (range of 11 ng/mL to 33 ng/mL), with over 
half of the study participants showing signs of stress fracture and unexplained muscle pain
38
 
(Table 4).  Clark, et al
148
 and Halliday, et al
146
, both studied NCAA Division I athletes and both 
groups concluded that vitamin D intake was inadequate. However, Halliday, et al
146
, found that 
vitamin D status or serum 25-OH D of NCAA Division I collegiate athletes was sufficient 
throughout the year regardless of intake. Clark, et al
148
, did not assess vitamin D status against 
intake as part of their analysis (Table 4).  
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Table 4. Vitamin D Intake of Highly Trained Athletes 
Study Participants Assess Index Vitamin D Intake 
(IU) 
Rankinen, et al
147
 
1998 
 
21 Finnish Elite Male Ski 
Jumpers,  
age 16-22 
 
4 day food recall 28-172 IU 
Lehtonon-Veromaa,  
et al
36
 
1999 
66 competitive runners, 
65 competitive gymnast, 
60 non athletic controls 
Age 9-15 
 
FFQ  
4 day food recall 
FFQ: 88-256 IU 
4 day food Recall: 
56-176 IU 
Clark, et al
148
 
2003 
 
 
13 female NCAA Div. 1 
soccer player,  
age 19 
3 day food recall Pre-season:90-102 IU 
Post-season:0-204 IU 
Lovell, et al 
2008 
 
18 Australian Elite 
Gymnast,  
age 10-17 
 
FFQ Not Reported 
Halliday, et al
146
 
2011 
41 Div. I collegiate 
athletes 
FFQ Fall: 403-81 IU 
Winter: 488-76 IU 
Spring: 375-33 IU  
 
Low exogenous vitamin D, a contributing factor to low vitamin D status, may be linked 
to diminished athletic performance
37
. Two studies reported that vitamin D supplementation may 
improve the performance
34,146
. These effects were observed only in athletes who were deficient or 
insufficient
34
. These studies imply that vitamin D supplementation has the potential to improve 
muscle power and strength in athletes with low vitamin D concentrations.  
The prevalence of vitamin D inadequacy among the collegiate athletic population is 
likely to be high, due to lifestyle factors and unhealthy food choices
36
. Evidence from human and 
animal studies has demonstrated that there is a positive association between vitamin D 
concentration and muscle strength and power. This association may be due to: 1) calcium 
regulation in the sarcolemma, 2) phosphorus regulation, or 3) muscle cell proliferation
28
. 
Supplementation of vitamin D has the potential to improve vitamin D status, and could 
potentially lead to gains in strength and power.  Should vitamin D status be found to highly 
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correlate with muscle strength and power performance measures, additional research will be 
needed to examine the extent to which supplementation can improve athletic performance  in 
highly trained athletes
39
.   
Conclusion 
 Current literature suggest that in non-athletic populations there is a correlation between 
vitamin D status and muscular strength and power
39
. Among the athletic population, vitamin D 
serum concentrations may also be low due to: 1) little sun exposure, 2) the latitude of where they 
practice or play, 3) ethnicity, and 4) dietary intake. As such, the sun is an unreliable source for 
athletes to meet their daily vitamin D requirement, and dietary sources may be limited
9,12,37
.  To 
date, there is very little data on the vitamin D status of collegiate athletes and only one study on 
post-menarchal adolescent girls that focused on the correlation of vitamin D status to 
performance measures. It is important to determine if collegiate athletes have adequate 
concentrations of vitamin D, what factors contribute to a lack of serum 25-OH D, and whether 
vitamin D status affects performance as measured by muscle strength and power. 
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CHAPTER III 
 
 
METHODOLOGY 
 
Study Design  
The purpose of this study was to: 1) determine the prevalence of vitamin D 
deficiency/insufficiency in a cross section of NCAA collegiate athletes and 2) evaluate the 
relationship between vitamin D status and muscle strength and muscle power. This purpose was 
accomplished by using a cross-sectional study design to evaluate the current vitamin D status of 
collegiate athletes and indicators of muscle strength and muscle power.  
Subjects  
Participants were male and female NCAA collegiate athletes (n=103) representing 
NCAA Divisions IA, IAA and II. They were recruited from The University of Tulsa (TU), 
Oklahoma State University (OSU) and Southern Nazarene University (SNU) over a 2 year period 
of time. Participants were recruited though the respective athletic training staff, strength and 
conditioning staff and coaches. All participants were 18 years of age or older and provided 
written consent for participation. Inclusion criteria were clearance by a physical exam 
administered by the respected medical staff. Exclusion criteria included any current injury (acute 
or chronic) that prevented the subject from completing the performance measures, the 
consumption of any sport supplement that may alter the physiological effects 
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 of strength and/or power production, and the inability to provide a viable blood specimen. Sport 
supplements that were considered to interfere with vitamin D status included creatine, whey 
protein, and supplements containing additional branch-chain amino acids. 
General Procedures  
Flyers describing the research study were sent to athletic training staffs, strength and 
conditioning staffs and coaches prior to meeting with the respective team representative. The 
team representative then contacted the Primary Investigator (PI) to discuss the research protocol 
and to determine when the team could participate in the research study. 
At each school, the PI met with the teams to provide an explanation of the study and 
allow time for questions about the protocol. Subjects were allowed to take a folder containing the 
Health History Questionnaire (HHQ), Food Frequency Questionnaire (FFQ), Calcium 
Questionnaire (CQ) and Sun Exposure Questionnaire (SEQ) home with them and return them the 
following day. Additional questionnaires were available on site the day of testing if needed. It 
should be noted that participants were asked to include the time spent in a tanning bed as a part of 
the SEQ inquiring about sun or UV exposure. On the day of testing, the PI reviewed the testing 
protocol with each investigator at designated stations. Subjects underwent anthropometric 
measures of height, body weight, body composition, and girth measurements. Participants then 
proceeded to the respective testing areas to complete the performance measures of Vertical Jump 
Test, Shuttle Run Test, Triple Hop for Distance Test and a 1 Repetition Maximum (1 RM) Squat 
Test. Next, the subjects went to a designated area where a trained, licensed phlebotomist collected 
approximately 10 cc of venous blood from the non-dominant arm for analysis of vitamin D (i.e., 
25-OH D). The samples were kept on ice and then centrifuged at 3,000 rpm. The serum was 
separated into 4 x 1,000 mL aliquots, and stored at -80°C.  
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Demographic and Anthropometric Data 
Demographic data were collected and included ethnicity, gender, general health and 
injury history, and information about the average number of hours of sun exposure for the week 
prior to testing. Anthropometric data collection incorporated height, weight, skin tone analysis, 
body composition, and circumference measures. Height and weight were determined using a 
Decto Standing Physicians Scale (Decto, Webb City, MO).  
Seven site skin-fold measurements were performed on each participant. Anatomical sites 
of measurement included: abdomen (one inch adjacent to umbilicus), midaxilla (four inches 
lateral to the xiphoid process), subscapula (midway between the vertebral border and inferior 
angle), triceps (midway between the acromium and olecranon process), suprailium (crest of 
ilium), thigh (midway between the anterior inferior iliac spine and superior patellar pole), and calf 
(medial aspect at maximum circumference of gastrocnemius) using the Jackson-Pollack equation 
to determine body composition
149
.  Body circumference (i.e., girth) measures were assessed using 
a Medco Sports Medicine Measuring Tape (Medco, Tonawanda, NY) at the waist, hip, upper 
arm, mid-thigh and calf. The girth measurements were taken at the cross sectional site with the 
greatest girth.  
Food Frequency Questionnaire 
The FFQ was a 12 point questionnaire that assessed vitamin D supplement usage and 
dietary intake of foods that are vitamin D rich
150
. This questionnaire has been validated by United 
States Food standards. In short, subjects were asked to recall how many servings of each item 
identified in the questionnaire they had consumed in the previous month. The IUs per item was 
adjusted to take into account the number of servings consumed by the participants to determine a 
monthly intake. To determine daily vitamin D consumption, the monthly was intake was divided 
by 31. Permission to use the FFQ and the key to determine the IU available in each item was 
kindly provided by J. Dahl, who was involved in designing the questionnaire. 
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Serum Vitamin D Status 
Non-fasting serum samples were used for the evaluation of 25-OH D. The vitamin D 
metabolite 25-OH D was assessed using a commercially available assay (Diasorin, Stillwater, 
MN). The assays were performed in collaboration with the Cooper Institute (Dallas, TX), where 
the guidelines set by the manufacture were followed.  
Performance Measures  
To assess muscular power and strength, 4 different performance measures were used 
including the incremental test for peak power (i.e., shuttle run), 2 iso-inertial tests (i.e., vertical 
jump test and the 1 legged triple hop for distance)
151
, and a 1 RM squat that assessed maximal 
strength.  
The Vertical Jump test was evaluated using a combination of the Tendo Weightlifting 
Analyzer V-207 (Sorinex, Irmo, SC) and contact mat. The TENDO unit cord was attached to a 
nylon buckle and fastened around the athletes waist with the unit placed flat on the floor behind 
the subject. This placement allowed for valid readings to be obtained without interfering with 
jump technique. The contact mat was placed under the athlete’s feet to record the time from when 
the athlete’s feet left the mat to the point when they returned. Subjects performed a series of 3 
maximal jumps with their hands on their hips to prevent momentum from the upper body. A 30 
second rest interval was allowed between each jump. The average of the 3 recordings was used 
for maximal jump force. Tendo Weightlifting Analyzer Output provided vertical height (d), 
power (P), and time in the air (t). Force was calculated using the formula F=P*t/d.  
The One Legged Triple Hop for Distance test was used to assess lower extremity power 
output. A single measuring tape was fixed to the floor up to 6 meters. The subject stood on their 
dominant leg, which was defined as the “kicking leg”. With the verbal prompt of “1, 2, 3, Go” the 
athlete performed 3 maximal hops on the dominant leg
149,151
. The subject performed 3 maximal 
trials with an average taken for record. 
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The Shuttle Run test has been shown to have high reliability in relation to the functional 
power and endurance
152
. Subjects began at the baseline of the court, sprinted to a specified 
distance, rapidly decelerated to a stop, turned 180 degrees, and sprinted to the baseline where they 
decelerated again, turned 180 degrees and sprinted a new distance. The series of sprints were 3 
consecutive tests with a 10 second rest between each run. The start and stop time measured for 
power.  
The 1 RM squat is a maximal effort test and was performed on Nautilus Xplode Plate 
Loaded Squat Rack (Nautilus, Vancouver, WA). 1 RM was assessed by placing 120, 150 or 200 
pounds (varied by sport and gender) on the bar and asking the subject to “lift as many times 
possible”. The 1 RM was determined when the subject could no longer complete full knee 
extension without assistance.  
Statistical Analysis 
Due to the limited number of participants, sports were combined for the analysis by sport 
creating an other group for both the men (i.e., cheer and track) and women (i.e., rowing, tennis 
and track). Descriptive statistics were calculated using SPSS version 21.0 (IBM, Armonk, NY) 
for all outcome variables including means, standard deviations, medians, minima and maxima. 
Outliers were identified as being > 2 standard deviations from the mean and removed from 
analysis. Data were analyzed using chi square frequencies, bivariate correlation, analysis of 
variance (ANOVA) and analysis of covariance (ANCOVA). Analysis of demographic groups 
(gender, ethnicity, sun exposure, body mass index (BMI), body composition and sport) utilized a 
cross tabulation Chi Square to determine the frequency of occurrence within vitamin D categories 
(i.e., deficient, insufficient and adequate). Chi Square cross tabulation was also used to determine 
the frequency distribution of subjects by performance measure normative value groups within 
each of the vitamin D categories. Significant differences between normative values within 
vitamin D status were calculated using a standardized z-score by SPSS. Within Body Mass Index 
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and Body Composition (% fat), the overweight and obese categories were collapsed to increase 
cell sizes for analysis. ANOVA was also used to analyze mean vitamin D concentrations for 
anthropometric measures, body composition based on normative values
153
, and dietary intake. 
The relationship between vitamin D concentration and indices of muscular strength and 
muscular power were explored using bivariate correlation analysis. The scores of performance 
measures in relation to the vitamin D concentration were graphed as a scatter plot with Microsoft 
Excel. One-way analyses of variance were used to compare the mean vitamin D concentration 
within the demographic characteristics of gender, ethnicity, BMI, body composition and sport. 
Where appropriate pairwise comparisons were evaluated using a Tukey HSD post hoc analysis. 
An ANCOVA was conducted to determine the effect of vitamin D status on calculated muscle 
strength and power controlling for lean mass, using a Sidak post hoc analysis. Lean mass was 
chosen as the covariate due to the high colinearity lean mass shared with vitamin D status. The 
significance level for all analyses was set at p < 0.05. 
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CHAPTER IV 
 
 
RESULTS 
 
Demographic Characteristics of the Study Population 
 NCAA athletes (n = 113) were consented in this study, of which 103 (91.1%) completed 
and were eligible for analysis. The reason participants (n= 10) failed to complete the study was 
the inability to provide an adequate blood sample. Athletes from three different universities, 
representing 12 NCAA collegiate sports participated in the research study. Of the population, 
66.0% competed in NCAA Division II athletics while 18.8% competed in NCAA Division IA and 
the remaining 14.8% competed in NCAA Division IAA (Table 5). The majority of the subjects 
were in their sophomore, junior and senior years, while 16.5% represented the freshman class and 
< 1% represented 5
th
 year seniors (Table 5). Of the 12 teams that were represented in the study, 8 
were women’s teams and 4 were men’s teams (Table 5).  
Sixty-eight females and 35 males participated in the study (Table 6). Body mass index 
(BMI) was calculated from measured height and weight; while percent fat was determined using 
skin fold measurements. Based on the recommended BMI (i.e., healthy = 18.5-24.9), the average 
BMI of the study population (25.7 ± 5.2) was classified as overweight (Table 6). The 
recommended range for percent body fat for healthy females, age 20-40 years, is 21%-33%, and 
for healthy males 20-40 years, 8%-19% body fat. Based on the mean BMI and percent fat, 
females were within the “healthy” ranges (Table 6). In contrast, the mean for the males was 
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overweight based on BMI and were 8.7% over the healthy range in percent fat mass classifying 
them as overweight (Table 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data is represented as number of subjects (percentage of the total study population). 
  
 
Evaluation of dietary intake of vitamin D and calcium was based on a self-report FFQ 
and a calcium questionnaire. The average intake for vitamin D was 187.7 ± 226.5 IU, which is 
31.1% of the RDA or 600 IU of vitamin D per day (Table 6). The vitamin D intake ranged from 
0-1100 IU per day, with some participants not reporting any dietary vitamin D intake over the 
past month in their FFQ. Females consumed 50.3 IU more vitamin D per day of than males 
(Table 6). The comparison of dietary vitamin D intake means across vitamin D deficient, 
insufficient and sufficient status resulted in no significant differences (data not shown). In 
contrast to the low vitamin D intake relative to the RDA, daily calcium intake exceeded the RDA 
of 1.0 g per day by 230% (Table 6). There was no difference in dietary intake of calcium between 
males and females (Table 6).  For all but 3 participants, the primary source of calcium intake was 
Table 5. Study Population Characteristics by NCAA Division, Academic 
Classification and Sport  
Characteristic       Overall 
n (%) 
NCAA Division  
   NCAA Division IA 19 (18.8) 
   NCAA Division IAA 16 (14.8) 
   NCAA Division II 68 (66.0) 
Academic Classification  
   Freshman 17 (16.5) 
   Sophomore 30 (29.1) 
   Junior 28 (27.2) 
   Senior 27 (26.2) 
   5
th
 Year 1 (1.00) 
Sport  
   Women’s Basketball 13 (12.6) 
   Volleyball 11 (10.7) 
   Women’s Cheer 11 (10.7) 
   Softball 13 (12.6) 
   Women’s Soccer 10   (9.7) 
   Baseball  13 (12.6) 
   Football 12 (11.7) 
   Women’s Other (Rowing, Track, Tennis) 10   (9.7) 
   Men’s Other (Cheer and Track) 10   (9.7) 
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from food sources and not calcium supplements (data not shown). Sun exposure was reported for 
the week previous to testing in a range of 0-2 with 0 representing < 5 minutes of sun exposure, 1 
representing 5 - 30 minutes of sun exposure and 2 representing > 30 minutes sun exposure. Males 
and females received approximately the same amount of sun exposure with an overall average of 
1.53 ± 0.48 (Table 6). Even with low vitamin D intake, participates were getting adequate sun 
exposure with 93.1% reporting at least 5 - 30 minutes per day in the sun the week prior to data 
collection. Only 6.9% reported less than 5 minutes per day in the sun (data not shown). 
 
Data presented as mean + SD. *RDA for vitamin D= 600 IU per day7 **RDA for calcium = 1.0 g per day7 
 
Comparison of Serum 25-OH D Concentration by Gender, Ethnicity, BMI, Percent Body 
Fat and Sport 
Subjects were tested over a two year period of time in either late spring, late summer, or 
early fall.  Time of year had no statistically significant effect (p = 0.78) on vitamin D status (data 
not shown). The incidence of vitamin D deficiency, insufficiency and sufficiency was 8.9%, 
22.7%, and 68.3% of the population, respectively. The distribution frequency was evaluated using 
a chi square test and the differences in means were determined using an ANOVA. The range of 
serum 25-OH D concentrations of the study population was 30-70 ng/mL for those in the 
Table 6. Age, Anthropometric, Vitamin D and Calcium Intake of NCAA Collegiate 
Athletes 
Characteristic 
n 
Overall 
103 
Males 
35 
Females 
68 
Age (yrs) 20.6 ± 1.9 20.7 ± 1.7 20.6 ± 1.9 
Anthropometrics    
   Height (cm) 171.7 ± 10.1 179.3 ± 6.7 167.8 ± 9.4 
   Weight (kg) 76.3 ± 16.9 89.1 ± 14.0 69.7 ± 14.3 
   Body Mass Index 25.7 ± 5.2 27.7 ± 4.2 24.7 ± 5.4 
Body Composition    
   Fat Mass (%) 23.1 ± 6.7 20.4 ± 7.0 24.4 ± 6.1 
   Lean Mass (kg) 17.9 ± 5.3 21.7 ± 4.4 15.9 ± 4.6 
Dietary Intake    
   Vitamin D Intake (IU)* 187.7 ± 226.5 154.4 ± 209.8 204.7 ± 234.3 
   Calcium Intake (g)** 2.3 ± 1.8 2.3 ± 1.8 2.2 ± 1.8 
Sun Exposure  1.53 ± 0.48 1.67 ± 0.42 1.46 ± 0.50 
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sufficient groups, and 21-29 ng/mL for those in the insufficient group and 11-19 ng/mL for those 
in the deficient group (Figure 2). As expected, when the mean serum vitamin D concentrations 
were compared, participants in the deficient and insufficient category had significantly lower 
serum 25-OH D concentrations (p < 0.01) compared to participants in the sufficient category 
(Figure 2). Athletes in the insufficient category had higher serum 25-OH D (p = 0.01) than those 
within the deficient category (Figure 2).  
 
 
 
 
To examine the differences in serum 25-OH D by gender, ethnicity, BMI, percent body 
fat and sport, one-way ANOVA were conducted. Females had higher serum 25-OH D (p = 0.03) 
compared to males (Table 7). African American and the other ethnic groups had significantly 
lower serum 25-OH D compared to Caucasians (p < 0.001) (Table 7). The other group included 
Figure 2. Study participants’ serum 25-OH D distributed by vitamin D status (Deficient <20 ng/mL; 
Insufficient 20-29 ng/mL; sufficient ≥ 30 ng/mL).  Bars show the distribution of participants within each 
category with the dark line within the bar indicating the mean. Bars that do not share the same superscript 
letter are statistically different from each other (p < 0.05).  
 
a 
b 
c 
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study participants that were Hispanic, Latin and Asian Pacific. Vitamin D status was altered 
relative to BMI and body composition. Based on BMI, overweight/obese participants had lower 
(p = 0.01) serum 25-OH D compared to participants with a BMI in the normal range (Table 7). 
The comparison of body composition (i.e., % fat) and serum 25-OH D reflects similar results. 
Participants with % fat in the overweight/obese categories had lower serum 25-OH D 
concentration (p = 0.01) compared to those with percent body fat classified as normal or 
underfat (Table 7). In comparing serum 25-OH D concentrations across sports, football players 
had a lower (p< 0.05) 25-OH D than volleyball players, but all other pairwise comparisons 
revealed no significant differences between sports (Table 7). 
Table 7. Comparison of 25-OH D Concentrations by Gender, Ethnicity, BMI, 
Percent Body Fat and Sport of  NCAA Athletes  
Characteristic n 
Vitamin D Concentration 
(ng/mL) 
Mean ± SD p-value 
Gender   0.03 
   Female 66 38.4 ± 12.5
a
  
   Male 35 32.6 ± 12.4
b
  
Ethnicity   0.00 
   Caucasian 76 39.4 ± 11.6
a
  
   African American 12 25.1 ± 10.8
b
  
   Other 13 28.9 ± 12.2
b
  
Body Mass Index   0.01 
   Normal 51 39.5 ± 12.1
a
  
   Overweight/Obese 50 33.0 ± 12.7
b
  
Body Composition (% Fat)   0.01 
   Underfat 23 37.7 ± 12.9
a
  
   Normal 58 38.4 ± 12.8
a
  
   Overweight/Obese 20 29.0 ± 10.1
b
  
Sport   0.04 
   Women’s Basketball 11 32.4 ± 8.6b,c  
   Volleyball 11 44.0 ± 10.3
a,b
  
   Women’s Cheer 11 42.2 ± 15.2b,c  
   Softball 13 39.4 ± 13.9
b,c
  
   Women’s Soccer 10 35.3 ± 7.8b,c  
   Baseball 13 31.6 ± 6.9
b,c
  
   Football 12 27.8 ± 11.3
c
  
   Women’s Other 10 36.4 ± 15.7b,c  
   Men’s Other 10 39.7 ± 16.7b,c  
     Comparison of mean 25-OH D concentrations using ANOVA. Data presented as mean + SD 
     For a given characteristic, means that do not share the same superscript letter are statistically different from each other 
     Level of significance set at p < 0.05 
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Distributions of Study Participants by Vitamin D Status 
 
The frequency distributions of the study population within a vitamin D status category 
(i.e., deficient, insufficient, and sufficient) was evaluated according to gender, ethnicity, BMI, 
body composition, and sport (Table 8). There was no statistically significant difference in the 
distribution of study participants by gender in the deficient, insufficient or sufficient categories. 
The frequency distribution of athletes across ethnic groups was significantly different (p< 0.001) 
by vitamin D status (Table 8). Caucasian participants were more likely to be sufficient or 
insufficient; compared to African American or other ethnicities (Table 8). Interestingly, there 
were no differences in distribution of participants by vitamin D status based on sun exposure 
(Table 8). BMI category distribution by vitamin D status did not reach the level of statistical 
significance. There was a trend (p = 0.06) toward more participants with a normal BMI in the 
sufficient category (Table 8). There were also no statistically significant differences in the 
distribution of study participants across body composition and sport categories by vitamin D 
category that were observed (Table 8).    
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Table 8. Distribution of Study Participants by Vitamin D Status by Gender, 
Ethnicity, Sun Exposure, Body Mass Index, Body Composition and Sport 
 
Characteristic                      Vitamin D Status  
 Totals Deficient Insufficient Sufficient p-Value 
 n (%) n (%) n (%) n (%)  
Gender     0.21 
   Female 66 (65.3) 5 (55.6) 12 (52.2) 49 (71.0)  
   Male 35 (34.6) 4 (44.0) 11 (47.8) 20 (29.0)  
Ethnicity     0.00 
   Caucasian 76 (75.2) 1 (11.1) 14 (60.9)
a
 61 (88.4)
a
  
   African American 12 (11.8) 5 (55.6) 4 (17.4)
b
 3 (4.3)
b
  
   Other 13 (12.9) 3 (33.3) 5 (21.7)
b
 5 (7.2)
b
  
Body Mass Index     0.06 
   Normal 51 (50.4) 2 (22.2) 9 (39.1) 40 (58.0)  
   Overweight/Obese 50 (49.5) 7 (77.8) 14 (60.9) 29 (42.0)  
Body Composition (%Fat)     0.62 
   Underfat 23 (22.7) 1 (11.1) 5 (21.7) 17 (24.6)  
   Normal 59 (58.4) 5 (55.6) 12 (52.2) 41 (59.4)  
   Overweight/Obese 20 (19.8) 3 (33.3) 6 (26.1) 11 (15.9)  
Sport     0.29 
   Women’s Basketball 11 (10.8) 1 (11.1) 3 (13.0) 7 (10.1)  
   Volleyball 11 (10.8) 0 (0.0) 1 (4.3) 10 (14.5)  
   Women’s Cheer 11 (10.8) 1 (11.1) 1 (4.3) 9 (13.0)  
   Softball 13 (12.8) 2 (22.2) 4 (4.3) 10 (14.5)  
   Women’s Soccer 10 (9.9) 0 (0.0) 3 (13.0) 7 (10.0)  
   Baseball 13 (12.9) 0 (0.0) 5 (21.7) 8 (11.6)  
   Football 12 (11.9) 3 (33.3) 5 (21.7 ) 4 (5.8)  
   Women’s Other 10 (9.9) 1 (11.1) 3 (13.0) 6 (8.7)  
   Men’s Other 10 (9.9) 1 (11.1) 1 (4.3) 8 (11.6)  
Data is represented as the number of participants (percentage by vitamin D status category). 
A cross tabs chi square analysis was done to provide frequencies by category.  
For a given characteristic, column proportions (z-test) with different superscript letters indicate significantly different 
proportions within a vitamin D status category 
 
 
Evaluation of Performance Measures Based on Vitamin D Concentration 
 The relationships between serum 25-OH D concentration and performance measures 
associated with muscle strength and power were investigated first using Pearson product-moment 
correlation coefficient. Three measures of functional muscle power (i.e., height, speed and 
distance) were assessed based on the results of the Vertical Jump Test, Shuttle Run Test, and the 
Triple Hop for Distance Test, respectively. Although there was no significant correlation between 
vertical jump height and serum 25-OH D concentration (Figure 3a), an inverse relationship (p < 
0.05) was observed between 25-OH D concentrations and the average power calculated from the  
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Vertical Jump Test (Figure 3b). Likewise, there were no significant correlations between serum 
25-OH D and the Shuttle Run Test time (Figure 3c) and the Triple Hop for Distance Test (Figure 
3d).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Functional muscle strength was assessed by a 1 RM Squat and force generated was 
calculated from the Vertical Jump Test. No correlation was observed between 25-OH D 
concentrations and functional muscle strength based on the 1 RM Squat (Figure 4a), but there 
was an inverse relationship (p < 0.05) observed between 25-OH D concentrations and calculated 
force (Figure 4b). Correlations between performance measures and 25-OH D status were also 
evaluated based on gender and each sport separately. There were no changes in the correlations 
between performance measures and vitamin D concentrations observed when separated by gender 
and sport (data not shown), compared to correlations for the total sample. 
Figure 3- Correlations between 25-OH D concentrations and a) Vertical Jump height; b) average 
power calculated the Vertical Jump Test; c) Shuttle Run time; d) Triple Hop for Distance  
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Distribution of Athletes’ Performance Measures Based on Vitamin D Status 
The frequency distribution of participants’ performance measures within each vitamin D 
category was explored using chi square analyses.  Normative values for performance measures of 
a collegiate athletic population established by the American College of Sport Medicine (ACSM) 
were used. These analyses did not include calculated force or the Triple Hop for Distance Test 
due to lack of established norms. There was no difference in the distribution of the Vertical Jump 
Test scores (p = 0.50) within the deficient, insufficient and sufficient vitamin D categories, It 
should be noted that 96% of the participants scored in the average category (Table 9). 
Participants’ scores for the Shuttle Run Test did result in differences (p = 0.02) in distribution of 
performance levels within vitamin D status (Table 9).  Participants with either insufficient or 
sufficient vitamin D status were more likely to have an excellent performance measure for the 
Shuttle Run Test compared to those who scored in the average or poor categories. In contrast, 
there was no difference in the distribution of Shuttle Run Test scores in those who were vitamin 
D deficient. In terms of the 1 RM Squat scores, there were no differences in the distribution of 
study participants by vitamin D status, however, there is a trend (p = 0.09) of participates who 
Figure 4- Correlations between 25-OH D concentrations and a) 1 RM Squat and; b) force calculated from 
the Vertical Jump Test  
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performed in the excellent category to have sufficient vitamin D status (Table 9). The calculated 
power measure from the Vertical Jump Test resulted in no significant differences in frequency 
distributions within vitamin D status (Table 9). 
 
Data is represented as number of subjects (percentage of vitamin D status). 
A chi square analysis was done to provide frequencies by category.  
For a given characteristic, column proportions (z-test) different superscript letters indicate significantly different 
proportions. 
 
 
Evaluation of Performance Measures of the Subject Population Based on Vitamin D Status  
Comparisons of the mean functional and calculated performance measures based on 
vitamin D status were accomplished using an ANOVA analysis (Table 10). There were no 
significant differences in performance measures by vitamin D status for the Vertical Jump Test, 
Shuttle Run Test, Triple Hop for Distance Test, and 1 RM Squat. However, there were significant 
differences in calculated performance measures by vitamin D status with participants 
demonstrating lower performance output as vitamin D status improved (Table 10). Participants in 
Table 9. Frequency of Study Participants’ Functional Performance Indicators  
 
Functional Performance 
Measure 
 Vitamin D Status  
 Total Deficient Insufficient Sufficient p value 
Vertical Jump (cm)     0.50 
   Excellent 4 (4.0) 1 (11.1) 1 (4.3) 2 (2.9)  
   Average 96 (96.0) 8 (88.9) 22 (95.7) 66 (97.1)  
   Poor 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)  
Shuttle Run (s)     0.02 
   Excellent 90 (89.1) 5 (55.6) 22 (95.7)
a
 63 (91.3)
a
  
   Average 5 (5.0) 2 (22.2) 0 (0.0)
b
 3 (4.3)
b
  
   Poor 6 (5.9) 3 (22.2) 1 (4.3)
b
 3 (4.3)
b
  
1 RM Squat (kg)     0.09 
   Excellent 94 (93.1) 7 (77.8) 21 (91.3) 66 (95.7)  
   Average 6 (5.9) 2 (22.2) 1 (4.3) 3 (4.3)  
   Poor 1 (1.0) 0 (0.0) 1 (4.3) 0 (0.0)  
Calculated Performance 
Measure  
     
Power (W) (Calculated from Vertical Jump Test) 0.54 
  Excellent 53 (53.0) 7 (77.8) 13 (56.5) 33 (48.5)  
  Average 30 (30.0) 1 (11.1) 7 (30.4) 22 (32.4)  
  Poor 17 (17.0) 1 (11.1) 3 (13.0) 13 (19.1)  
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the sufficient category had a lower power output (p = 0.01) compared to participants in the 
insufficient and deficient categories.  Furthermore, those participants in the insufficient category 
had lower power output (p < 0.001) compared to participants in the deficient category (Table 10). 
Participants with sufficient vitamin D produced less force calculated from the Vertical Jump Test 
compared to those with insufficient and deficient status; and participants who were insufficient 
produced less force than those who were deficient (Table 10). In general, these findings suggest 
that improved vitamin D status resulted in less capacity for force production than participants 
with compromised vitamin D status (Table 10). 
 
ANOVA data presented as mean + SD 
*Power calculated from Vertical Jump Test; **Force calculated from Vertical Jump Test.  
For a given characteristic, means that do not share the same superscript letter are statistically different from each other.   
Level of significant at p <  0.05 
 
 
 
Because lean body mass could potentially confound the evaluation of vitamin D status on 
muscle strength and power performance measures, an ANCOVA was performed controlling for 
lean body mass.  In the Vertical Jump Test and Triple Hop for Distance Test, controlling for lean 
body mass resulted in no differences in the mean scores by vitamin D status (Table 11). The 
Shuttle Run Test time tended (p = 0.07) to decrease as vitamin D status improved when adjusting 
for lean body mass (Table 11). Moreover, the mean performance for the 1 RM Squat was 
statistically different across vitamin D status (p = 0.03) when controlling for lean muscle mass 
Table 10.  Comparison of Performance Measure Means by Vitamin D Status  
 
Functional Performance 
Measure 
 Vitamin D Status  
 n Deficient Insufficient Sufficient p value 
Vertical Jump (cm) 100 16.2 ± 5.1 16.9 ± 3.6  16.2 ±3.4 0.67 
Shuttle Run (s) 101 9.5 ± 1.9 8.8 ± 1.0 9.0 ± 1.1 0.30 
Triple Hop for Distance (cm) 101 489.0 ± 133.3 520.7 ± 80.0 509.3 ± 81.1 0.64 
1 RM Squat (kg) 101 154.0 ± 58.8 150.0 ± 72.6 176.8 ± 150.5 0.96 
Calculated Performance 
Measure  
     
Power (1 x 10
3
 W)* 100 1.13 ± 0.36
a
 1.05± 0.32
b
 0.88 ± 0.26
c
 0.01 
Force (1 x 10
3
 N)** 100 2.04 ± 0.61
a
 1.81 ± 0.46
b
 1.54 ± 0.40
c
 0.00 
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(Table 11). Post hoc analyses revealed that the amount of weight that could be lifted in the 1 RM 
Squat was greater (p = 0.05) in the participants who had sufficient vitamin D compared to those 
who were deficient (Table 11). The maximum squat lifted was 48.0% less in the vitamin D 
deficient group compared to participants in the vitamin D sufficient groups (Table 11). Although 
the comparison of the 1 RM Squat was 33.0% less for participants in the insufficient group 
compared to the sufficient groups, differences between these two groups did not reach the level of 
statistical significance (p = 0.65 ). Interestingly, no significant differences were observed by 
vitamin D status on calculated muscle power and force (Table 11).  These data suggest that lean 
muscle mass accounted for the negative effects of vitamin D status that were observed on the 
calculated performance measures when compared across vitamin D status. 
 
 
ANCOVA data presented as mean + SD with muscle mass as the covariate followed by Sidak post hoc test for pairwise 
comparisons. 
*Power calculated from Vertical Jump Test; **Force calculated from Vertical Jump Test.  
For a given characteristic, means that do not share the same superscript letter are statistically different from each other   
Level of significant at p < 0.05. 
Table 11.  Comparison of Performance Measure Means by Vitamin D Status Adjusted for  
Muscle Mass  
Functional Performance 
Measure 
 Vitamin D Status  
 n Deficient Insufficient Sufficient p value 
Vertical Jump (cm) 100 14.8 ± 1.2 16.3 ± 0.7  16.5 ±0.4 0.38 
Shuttle Run (s) 101 9.8 ± 0.4 9.0 ± 0.2 8.9 ± 0.1 0.07 
Triple Hop for Distance (cm) 101 460.5 ± 28.3 509.3 ± 17.3 516.9 ± 10.0 0.19 
1 RM Squat (kg) 101 100.0 ± 41.3
a
 128.0 ± 25.3
a,b
 191.2 ± 14.7
b
 0.03 
Calculated Performance 
Measure  
     
Power (1 x 10
3
 W)* 100 0.91 ± 0.06 0.95± 0.4 0.94 ± 0.02 0.83 
Force (1 x 10
3
 N)** 100 1.77 ± 0.12 1.70 ± 0.73 1.60 ± 0.42 0.29 
56 
 
CHAPTER V 
 
 
DISCUSSION OF RESULTS 
 
This study was designed to determine the prevalence of inadequate vitamin D status in 
NCAA athletes and to explore the relationship between vitamin D status and muscular strength 
and muscular power. The study population was recruited from three different universities within 
the state of Oklahoma and represented three different divisions of NCAA competition. The 
findings of this study revealed that the majority of this group of athletes (i.e., 68.3%) had serum 
25-OH D levels that would be considered sufficient and only 31.7% were considered vitamin D 
insufficient or deficient. The prevalence of inadequate vitamin D status observed in this study is 
was not as high as has been reported in the general population; however, a number of these 
studies have focused on vitamin D status in older adults or adolescents
1,4,49,66,68,69
.  
 Data from studies examining the prevalence of vitamin D inadequacy in collegiate and 
elite athletes have shown that vitamin D status is highly variable in this population. In NCAA 
collegiate athletes at the University of Wyoming, only 2.4% failed to maintain serum 25-OH D > 
30 ng/mL throughout the academic year, regardless of sport
146
.  Maimoun and colleagues
154
 
showed that elite cyclists had an average of 33 ng/mL serum 25-OH D and reported that 44% of 
the athletes had inadequate serum 25-OH D. Lehtonon-Veromaa and others
36
 observed that 
approximately 11.3% of elite Finnish gymnasts (i.e., 9-15 years of age) were vitamin D
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inadequate. The 31.7% of the athletes in the present study that had serum 25-OH D below 
recommended levels demonstrate that compromised vitamin D status is a health concern in this 
population.  
The high proportion of athletes in the study with sufficient vitamin D could not be 
explained by vitamin D intake. Based on the results of the FFQ, study participants had a mean 
vitamin D intake of 31.1% (i.e., 187.7 IU) of the 600 IU per day RDA. Other studies that have 
examined vitamin D intake among collegiate athletes have also reported that the RDA was not 
being met
147,148
. For example,  Rankinen and colleagues
147
 concluded that elite Finnish ski 
jumpers had vitamin D intakes of 28-172 IU per day. Similarly, Clark, et al
148
 reported that 
NCAA Division I soccer players had vitamin D intakes ranging from 0-204 IU per day. In the 
current study, vitamin D intake ranged from 0-1,100 IU per day, with a mean intake of 187.7 ± 
226.5 IU per day. These studies in conjunction with the results of the current study indicate that 
collegiate athletes are not meeting the vitamin D dietary requirement.    
Even with relatively low dietary intake of vitamin D, the majority of the participants in 
the current study had sufficient vitamin D status. This observation might be explained by sun 
exposure. Optimal subcutaneous synthesis of vitamin D (i.e., pre-vitamin D ceases to be 
converted to vitamin D) can be achieved with an average of 20 minutes unprotected exposure to 
UV rays (i.e., without sunscreen or other topical agents)
84
. The RDA for dietary vitamin D intake 
assumes that an individual is not meeting the sun exposure requirements, therefore the IOM made 
the dietary recommendation for vitamin D intake based on minimal sun exposure
7
. 
Approximately 53% of participants in this study reported average daily sun exposure of 5-30 
minutes the week prior to testing, with 39.6% of those getting > 30 minutes per day. Only 6.9% 
had sun exposure < 5 minutes per day. These findings are consistent with the study by Halliday, 
et al
146
 who reported that participants were able to maintain sufficient vitamin D status by 
meeting the sun exposure recommendations (i.e., 31 minutes) even with low dietary vitamin D 
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intake. Taken together these studies suggest that a large portion of the athletes studied were 
meeting their vitamin D requirement over the course of the year through sunlight exposure.  
In addition to dietary vitamin D intake and sunlight exposure, there are other factors that 
may influence an athletes’ vitamin D status including ethnicity. In the present study, differences 
in serum 25-OH D were observed across ethnic groups. Caucasians had higher serum 25-OH D 
concentrations (i.e., sufficient) compared to African American and Other ethnic groups who were 
mostly deficient/insufficient. These findings were in agreement with Shea, et al
3
, who reported a 
serum 25-OH D in African American subjects of  21 ng/mL, while their Caucasian counterparts 
had serum 25-OH D of approximately 29 ng/mL throughout the year. Shindle, et al
155
 compared 
the vitamin D status of football players in the National Football League (NFL) across ethnic 
groups. They found that 25-OH D concentrations were significantly lower in African American 
players (20.4 ng/mL) compared to Caucasian players (30.0 ng/mL)
155
. This phenomenon may be 
due to the increase of melanin in the skin of ethnic groups with darker skin tone
156
. It should be 
noted that the current study sample was predominantly Caucasian (75.2%), with lighter skin 
tones, which may have contributed to the high serum 25-OH D.   
Body composition (i.e., percent fat) is also recognized as a factor that can influence 
serum 25-OH D. Individuals with high percent fat (i.e., males > 25%, females > 33%) or low 
percent fat (i.e., males < 8%, females < 18%) have been shown to be at increased risk for serum 
25-OH D levels below 30 ng/mL
14,21,153
.  Lenders and colleagues
14
 concluded that in a population 
of obese adolescents, body fat was inversely related to 25-OH D. In the current study, participants 
whose percent body fat was categorized as normal had higher vitamin D concentrations compared 
to those who were overweight or obese. Those athletes in the normal range had a mean serum 25-
OH D of 38.4 ± 12.1ng/mL and those in the overweight/obese had a mean serum 25-OH D of 
29.0 ± 10.1 ng/mL. Lagunova, et al
157
, reported that serum vitamin D was inversely correlated 
with morbid obesity based on BMI > 40. However, because athletes have higher percent lean 
mass, the authors suggested that fat mass may be a better predictor of 25-OH D than BMI
157
. 
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Additionally, Bartoszewska and colleagues
32
 demonstrated that vitamin D is stored in muscle 
tissue. It has been suggested that athletes who have higher lean muscle mass also have higher 
serum 25-OH D, but further research is needed to understand the relationship between lean 
muscle mass and vitamin D
157
.   
In addition to studying the prevalence of inadequate vitamin D status among athletes, this 
study was also designed to determine the extent to which vitamin D status influenced muscle 
strength and power. When the relationship between serum 25-OH D and functional performance 
measures (i.e., Vertical Jump Test, Shuttle Run Test, Triple Hop for Distance Test and the 1 RM 
Squat) was explored, no significant correlations were observed. Weak, but statistically 
significant, inverse correlations existed between serum 25-OH D and the calculated performance 
measures of power and force. When comparing mean performance scores across vitamin D status, 
athletes with sufficient vitamin D did not have improved scores compared to those with 
inadequate status. Furthermore, athletes with deficient vitamin D status had significantly higher 
calculated performance outputs for power and force than those who were sufficient. In order to 
determine if lean muscle mass was confounding these results, an ANCOVA was utilized to 
control for lean body mass. The negative effects of vitamin D sufficiency that were previously 
observed on calculated power and force were no longer evident when controlling for lean body 
mass. Athletes who were vitamin D sufficient tended to have faster Shuttle Run times than those 
who were vitamin D deficient, although this difference did not reach the level of statistical 
significance (p = 0.07). Furthermore, athletes who were vitamin D sufficient were able to lift 
more weight (kg) while performing a 1 RM squat than those who were vitamin D deficient. The 
only other study to evaluate the correlation between vitamin D and muscle power and strength 
utilizing some of the same measures used in the current study was conducted in a population of 
adolescent females who were not identified as athletes
18
. The researchers investigated the 
relationship between vitamin D status and the Vertical Jump Test and found that those with 
higher serum 25-OH D had improved performance for jump velocity, jump height, power and 
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force
18
.  Moreover, Barker and colleagues
27
, concluded that there was a positive correlation 
between serum 25-OH D concentrations and post-surgical quadriceps muscle strength
27
 in young 
adults. Studies with older adults have also shown improved muscle strength and power by testing 
the Timed Up and Go Test and Eight Foot Walk Test
23,26
. Bischoff-Ferrari and others
60
 reported 
that older adults with serum 25-OH D > 30 ng/mL were able to stand more quickly and walk 
farther than those who had serum 25-OH D < 30 ng/mL. Saadi and colleagues
63
 also 
demonstrated that older adults with sufficient vitamin D status were able to walk farther and 
noted a significant decrease in falls. These studies support that muscle performance is associated 
with higher levels of 25-OH D concentration. 
In the current study, the Shuttle Run Test represented a functional measure of power and 
the 1 RM Squat represented a functional measure of force. Shuttle Run Test times were 
approximately 1 second faster in those that were vitamin D sufficient compared to those who 
were deficient, even though statistically this resulted in only a trend toward faster times. 
Participants who were vitamin D sufficient had an approximately 2-fold higher squat compared to 
those who were vitamin D deficient. Although no significant difference in the 1 RM Squat was 
observed between athletes who were vitamin D sufficient and those who were insufficient (p = 
0.67), the vitamin D sufficient athletes had scores that were 1.5-fold higher than the athletes who 
were insufficient. It is well established that muscle power and strength are predictors of athletic 
performance and highly correlated with an athlete’s ability to perform at their highest level151,158-
160
. The performance measure data from this study suggest that better vitamin D status likely 
contributes to greater performance in both the Shuttle Run Test and 1 RM Squat and may 
translate to potential for a higher level of sport performance.  
In conclusion, the current study of collegiate athletes demonstrated that greater than 30% 
of the population was vitamin D inadequate indicating that one-third of the population may 
benefit from vitamin D supplementation. Furthermore, results of the current research indicate that 
athletes with higher vitamin D status had higher functional performance, specifically with the 
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Shuttle Run Test and 1 RM Squat, compared to athletes with deficient vitamin D status. These 
results reveal that athletes who are vitamin D deficient, or approximately 9% of the population, 
may experience compromised muscle strength and power. More research is needed to determine 
the factors that contribute to vitamin D deficiency and insufficiency among college athletes and to 
examine the extent to which vitamin D supplementation can improve serum 25-OH D and athletic 
performance in this population.  
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CHAPTER VI 
 
 
SUMMARY, CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE RESEARCH 
Summary 
 A high prevalence of vitamin D inadequacy has been documented among the general 
population
4
 and higher 25-OH D concentrations have been associated with greater muscle 
strength and power in older adult populations
26
. Research focused on serum 25-OH D and muscle 
strength and power in collegiate athletes has been limited. In the current study, NCAA Division 
IA, IAA and II athletes (n = 103) performed a battery of functional performance tests, completed 
a series of questionnaires related to factors known to affect vitamin D status and had 25-OH D 
serum concentrations and anthropometric measures assessed. Analyses of the data revealed the 
majority (i.e., 68%) of the study participants were vitamin D sufficient (i.e., > 30 ng/mL) and 
31.6% has inadequate vitamin D status. Factors influencing vitamin D status included ethnicity, 
body mass index, percent fat and sport. There were no significant correlations between vitamin D 
concentration and the Vertical Jump Test, Shuttle Run Test, Triple Hop for Distance Test and 1 
RM Squat scores. A weak inverse relationship existed between serum 25-OH D and calculated 
power and calculated force. However, when controlling for lean body mass, athletes who were 
vitamin D sufficient had a greater 1 RM Squat score compared to athletes that were vitamin D 
deficient. Furthermore, Shuttle Run Test times tended to be faster in athletes whose vitamin D 
status was sufficient compared to athletes who had vitamin D insufficient and deficient status 
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These findings indicate the prevalence of inadequate vitamin D status among this sample of 
collegiate athletes was lower than what has been reported in the general population, but was 
similar with studies conducted with elite and collegiate athletes
36,146
. The effect of vitamin D 
concentration on muscle strength is evident in the 1 RM Squat and concurs with a previous study 
conducted with post-menarchal females
18
.  
Conclusions 
The primary null hypotheses tested were: 
1) There will be no participants who are vitamin D deficient/insufficient in cross-section 
of collegiate athletes.  
Reject the null hypothesis. The distribution of study participants across vitamin D 
categories revealed that while most study participants were vitamin D sufficient 
(68.3%), 22.7% of the athletes were insufficient and 8.9% were deficient. Based on 
these findings the null hypothesis was rejected. 
 
2) Collegiate athletes with sufficient vitamin D status will not have higher Vertical 
Jump Test scores than those who are insufficient or deficient.  
Fail to reject the null hypothesis. Comparison of mean Vertical Jump Test scores 
among athletes that were deficient, insufficient or sufficient revealed that there was 
no statistically significant difference between vitamin D status and Vertical Jump 
height. When controlling for lean body mass, the comparison of mean Vertical Jump 
Test scores remained insignificant. Therefore, the null hypothesis was not rejected. 
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3) Collegiate athletes with sufficient vitamin D status will not have faster Shuttle Run 
Test times than those who are insufficient or deficient. 
Fail to reject the null hypothesis. Comparison of mean Shuttle Run Test times among 
athletes that were deficient, insufficient or sufficient revealed that there was no 
statistically significant difference between vitamin D status Shuttle Run times. When 
controlling for lean body mass, the comparison of mean Shuttle Run Test scores 
approached the statistical significance. However, based on these findings the null 
hypothesis was not rejected. 
 
4) Collegiate athletes with sufficient vitamin D status will not have longer Triple Hop 
for Distance Test scores than those who are insufficient or deficient. 
Fail to reject the null hypothesis. Comparison of mean Triple Hop for Distance scores 
among athletes that were deficient, insufficient or sufficient revealed that there was 
no statistically significant difference in Triple Hop scores by vitamin D status. When 
controlling for lean body mass, the comparison of mean Triple Hop for Distance Test 
scores remained insignificance. Based on these findings, the null hypothesis is not 
rejected. 
 
5) Collegiate athletes with sufficient vitamin D status will not have higher 1 Repetition 
Maximum (1 RM) Squat scores than those who are insufficient or deficient. 
Reject the null hypothesis. Comparison of mean 1 RM Squat scores among athletes 
that were deficient, insufficient or sufficient revealed that there was no statistically 
significant difference in 1 RM Squat score across vitamin D status groups. When 
controlling for lean body mass, the comparison of mean 1 RM Squat scores became 
significant with participants in the deficient vitamin D status significantly lower than 
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those in the vitamin D sufficient status. Based on these findings the null hypothesis 
was rejected. 
 
6) Collegiate athletes with sufficient vitamin D status will not have greater muscle 
power output scores based on the Vertical Jump Test than those who are insufficient 
or deficient. 
Fail to reject the null hypothesis. Comparison of mean calculated power scored based 
on the Vertical Jump Test among athletes that were deficient, insufficient or 
sufficient revealed that there was a statistically significant difference power output 
among participants with deficient vitamin D status compared to participants that were 
vitamin D sufficient. However, when controlling for lean body mass, no significant 
difference in calculated power scores was observed on vitamin D status. Therefore, 
the null hypothesis was not rejected. 
   
7) Collegiate athletes with sufficient vitamin D status will not have greater muscle force 
output scores based on the Vertical Jump Test than those who are insufficient or 
deficient. 
Fail to reject the null hypothesis. Comparison of mean calculated force scored based 
on the Vertical Jump Test among athletes that were deficient, insufficient or 
sufficient revealed that participants who were vitamin D deficient had significantly 
higher force outputs then those who were vitamin D sufficient. However, when 
controlling for lean body mass, the comparison of mean calculated force based on 
vitamin D status was not statistically significant. Based on these findings the null 
hypothesis was not rejected.  
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The ancillary null hypotheses tested were: 
1) There will be no difference in vitamin D status based on subject’s vitamin D intake in 
collegiate athletes. 
Fail to reject the null hypothesis. There was no significant difference in vitamin D 
intake across vitamin D status categories. Based on these findings the null hypothesis 
was not rejected. 
 
2) There will be no difference in vitamin D status based on the subjects sport.  
Fail to reject the null hypothesis. There was no statistically significant difference in 
the frequency of athletes by sport across vitamin D status categories. Based on these 
findings the null hypothesis is rejected.  
 
3) There will be no difference in vitamin D status based on subject’s gender in 
collegiate athletes.  
Fail to reject the null hypothesis. There was no statistically significant difference in 
the frequency of athletes by gender across vitamin D status categories. Based on 
these findings the null hypothesis is not rejected.  
 
4) There will be no difference in vitamin D status based on subject’s ethnicity in 
collegiate athletes.  
Reject the null hypothesis. There was a statistically significant difference in the 
frequency of athletes by ethnicity across vitamin D status categories. Based on these 
findings the null hypothesis is rejected.  
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5) There will be no difference in vitamin D status based on subject’s body composition 
(% fat) in collegiate athletes.  
Fail to reject the null hypothesis. There was no statistically significant difference in 
the frequency of athletes by body composition (% fat) across vitamin D status 
categories. Based on these findings the null hypothesis is not rejected.  
Recommendations for Future Research 
In this study, approximately one-third of the athletes in the study population had 
inadequate vitamin D concentrations. It is important to emphasize that the primary source of 
serum 25-OH D was not dietary intake which suggests that these findings cannot be extrapolated 
to other sports or other regions where sun exposure may vary.  Future research is first needed 
with a larger sample size to clearly establish if inadequate vitamin D status is an issue among 
collegiate athletes in Oklahoma. To determine the prevalence of vitamin D inadequacy in other 
populations of athletes, future studies need to be designed giving consideration to season of the 
year and latitude which can significantly affect sun exposure. If inadequate vitamin D status is 
established as a significant health issue among collegiate athletes, research will be needed to 
determine the contributing factors (e.g., sun exposure, latitude of residence, and vitamin D intake) 
so that health care professionals can utilize the information to identify individuals who should be 
monitored and might benefit from vitamin D supplementation.  
The results of this study also showed that athletes who had inadequate vitamin D status 
demonstrated lower performance outputs for the 1 RM Squat and a trend toward slower times in 
the Shuttle Run Test with decreased serum 25-OH D.  However, no other muscle power and 
strength performance measures reached the level of statistical significance.  Although there were 
103 participants in the current study, the population can be considered heterogeneous due to the 
inclusion of both males and females and athletes from 12 different sports teams. This approach 
resulted in having only 10-13 athletes from each sport or rather small cell sizes.  Future studies 
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investigating the relationship between vitamin D status and muscle power and strength should 
consider studying a larger and more homogenous study population.  
Based on the findings of this study, additional research is needed to determine if 
supplementing athletes who have inadequate vitamin D status would allow them to become 
vitamin D sufficient and improve performance outcomes. Using an experimental research design, 
participants should be recruited and screened based on vitamin D status and ethnicity to achieve 
equal sample sizes. The significance of this study would identify athletes who could benefit from 
vitamin D supplementation as an ergogenic aid and provide allied health care professionals with 
another tool to enhance rehabilitation of athletes after injury.   
Lastly, studies are needed to compare if vitamin D supplementation equally affects 
athletes who participate in a sport that specializes in power (e.g., power cling) and strength (e.g., 
1 RM Squat).  Using an experimental research design, participants would be recruited based on 
specialization and supplemented with vitamin D based on status. The significance of this research 
would aid the athletic community in further identifying athletes who may achieve gain in muscle 
strength and power resulting from improved vitamin D status. 
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